<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">57902</article-id><article-id pub-id-type="doi">10.7554/eLife.57902</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>A regulatory pathway that selectively up-regulates elongasome function in the absence of class A PBPs</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-185732"><name><surname>Patel</surname><given-names>Yesha</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9888-9888</contrib-id><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-185733"><name><surname>Zhao</surname><given-names>Heng</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7322-5513</contrib-id><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa1">†</xref></contrib><contrib contrib-type="author" corresp="yes" id="author-146462"><name><surname>Helmann</surname><given-names>John D</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3832-3249</contrib-id><email>jdh9@cornell.edu</email><xref ref-type="aff" rid="aff1"/><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution>Department of Microbiology, Cornell University</institution><addr-line><named-content content-type="city">Ithaca</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Levin</surname><given-names>Petra Anne</given-names></name><role>Reviewing Editor</role><aff><institution>Washington University in St. Louis</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Storz</surname><given-names>Gisela</given-names></name><role>Senior Editor</role><aff><institution>National Institute of Child Health and Human Development</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>†</label><p>Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, United States</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>08</day><month>09</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e57902</elocation-id><history><date date-type="received" iso-8601-date="2020-04-15"><day>15</day><month>04</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-08-22"><day>22</day><month>08</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Patel et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Patel et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-57902-v1.pdf"/><abstract><p>Bacteria surround themselves with peptidoglycan, an adaptable enclosure that contributes to cell shape and stability. Peptidoglycan assembly relies on penicillin-binding proteins (PBPs) acting in concert with SEDS-family transglycosylases RodA and FtsW, which support cell elongation and division respectively. In <italic>Bacillus subtilis</italic>, cells lacking all four PBPs with transglycosylase activity (aPBPs) are viable. Here, we show that the alternative sigma factor σ<sup>I</sup> is essential in the absence of aPBPs. Defects in aPBP-dependent wall synthesis are compensated by σ<sup>I</sup>-dependent upregulation of an MreB homolog, MreBH, which localizes the LytE autolysin to the RodA-containing elongasome complex. Suppressor analysis reveals that cells unable to activate this σ<sup>I</sup> stress response acquire gain-of-function mutations in the essential histidine kinase WalK, which also elevates expression of <italic>sigI</italic>, <italic>mreBH</italic> and <italic>lytE</italic>. These results reveal compensatory mechanisms that balance the directional peptidoglycan synthesis arising from the elongasome complex with the more diffusive action of aPBPs.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>peptidoglycan</kwd><kwd>elongasome</kwd><kwd>antibiotic</kwd><kwd>penicillin-binding protein</kwd><kwd>cell wall</kwd><kwd>gene regulation</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>B. subtilis</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R35GM122461</award-id><principal-award-recipient><name><surname>Helmann</surname><given-names>John D</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Balanced peptidoglycan synthesis requires regulators, including sigma-I and WalKR, that coordinate the diffusive action of class A PBPs and the directional motion of the MreB-directed elongasome.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Nearly all bacterial cells are surrounded by a peptidoglycan (PG) cell wall that provides a protective barrier, helps resist cell swelling and lysis under hypoosmotic conditions, and contributes to cell shape determination (<xref ref-type="bibr" rid="bib22">Egan et al., 2020</xref>; <xref ref-type="bibr" rid="bib97">Zhao et al., 2017</xref>). PG functions as a large, covalently linked macromolecular enclosure and is actively remodeled to allow cell growth and division. The basic processes of PG synthesis are broadly conserved, and the detailed pathways are well documented. PG synthesis initiates with the diversion of sugars from central metabolism to form the two amino-sugars, N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM), and the incorporation of amino acids to form the stem peptide (<xref ref-type="bibr" rid="bib2">Barreteau et al., 2008</xref>). The ultimate product of these cytosolic reactions is lipid II, a disaccharide pentapeptide precursor unit linked to an undecaprenyl pyrophosphate carrier lipid (<xref ref-type="bibr" rid="bib87">van Heijenoort, 2007</xref>). Lipid II is flipped across the membrane (<xref ref-type="bibr" rid="bib75">Sham et al., 2014</xref>; <xref ref-type="bibr" rid="bib56">Meeske et al., 2015</xref>) where it interacts with two key enzymatic activities to assemble the PG layer: a transglycosylase (TG) function joins the disaccharide unit to form long, linear chains of alternating NAG-NAM residues, and a transpeptidase (TP) activity crosslinks a subset of the pentapeptide side chains to link the glycan strands together. Crucially, insertion of new glycan strands requires endopeptidases that can cleave existing crosslinks to facilitate cell wall expansion (<xref ref-type="bibr" rid="bib77">Singh et al., 2012</xref>; <xref ref-type="bibr" rid="bib30">Hashimoto et al., 2012</xref>; <xref ref-type="bibr" rid="bib18">Do et al., 2020</xref>).</p><p>Most bacteria require PG for survival, except under very specific conditions (<xref ref-type="bibr" rid="bib14">Claessen and Errington, 2019</xref>). This, combined with the absence of PG in eukaryotes, makes PG synthesis and stability an excellent target for antibiotics. One class of PG-targeting antibiotics, the beta-lactams, account for more than 60% of the global market (<xref ref-type="bibr" rid="bib45">Klein et al., 2018</xref>). Beta-lactam antibiotics interfere with PG synthesis by covalently modifying penicillin-binding proteins (PBPs), named for their affinity for the first widely used member of this drug family. All PBPs have TP activity, and beta-lactams mimic the substrate of the transpeptidation reaction (<xref ref-type="bibr" rid="bib83">Tipper and Strominger, 1965</xref>). Many PBPs also have TG activity, and these bifunctional PBPs are designated class A PBPs, or aPBPs (<xref ref-type="bibr" rid="bib55">McPherson and Popham, 2003</xref>). Other PBPs, designated bPBPs, only have TP activity, and must work in coordination with enzymes that provide TG activity (<xref ref-type="bibr" rid="bib93">Wei et al., 2003</xref>; <xref ref-type="bibr" rid="bib80">Taguchi et al., 2019</xref>; <xref ref-type="bibr" rid="bib68">Rohs et al., 2018</xref>; <xref ref-type="bibr" rid="bib61">Özbaykal et al., 2020</xref>).</p><p>While the basic outline of PG assembly has been understood for decades, the last few years have seen major strides in our understanding of how PG synthesis is coordinated in time and space (<xref ref-type="bibr" rid="bib97">Zhao et al., 2017</xref>; <xref ref-type="bibr" rid="bib22">Egan et al., 2020</xref>). Moreover, PG synthesis can be regulated as a function of cell growth, division, nutritional status, and in response to externally imposed stresses such as the action of antibiotics (<xref ref-type="bibr" rid="bib16">Delhaye et al., 2019</xref>; <xref ref-type="bibr" rid="bib85">Typas et al., 2012</xref>; <xref ref-type="bibr" rid="bib34">Helmann, 2016</xref>). <italic>B. subtilis</italic> has been a leading model system for understanding PG synthesis in rod-shaped, Gram-positive bacteria. Seminal work in this system established, for example, that the sites of PG synthesis during cell elongation seem to be correlated with cytoskeletal filaments assembled from MreB and its paralogs, MreBH and Mbl (<xref ref-type="bibr" rid="bib40">Kawai et al., 2009</xref>). This synthesis occurs in arcs that are perpendicular to the long access of the cell and is driven by a putative complex known as the elongasome (<xref ref-type="bibr" rid="bib27">Garner et al., 2011</xref>). Cell division, in contrast, occurs at mid-cell during vegetative growth and is directed by a different cytoskeletal filament, FtsZ, in a complex called the divisome (<xref ref-type="bibr" rid="bib53">Mahone and Goley, 2020</xref>). In early models, it was suggested that the major aPBP, PBP1 (encoded by the <italic>ponA</italic> gene), shuttled between the elongasome and divisome to provide the needed TG and TP activities (<xref ref-type="bibr" rid="bib13">Claessen et al., 2008</xref>). However, bPBPs clearly also play important roles in synthesis (<xref ref-type="bibr" rid="bib93">Wei et al., 2003</xref>). The composition and dynamic nature of these complementary systems has been subject of intensive study.</p><p>A key finding that challenged our understanding of PG synthesis in <italic>B. subtilis</italic> was the observation that a strain lacking all four known aPBPs was viable and still synthesized an apparently normal PG layer (<xref ref-type="bibr" rid="bib55">McPherson and Popham, 2003</xref>). This implied that there must be another protein with TG activity and, unlike aPBP-associated TG activity, this activity was insensitive to inhibition by moenomycin (MOE). MOE, like many PG synthesis inhibitors, activates the σ<sup>M</sup> stress response (<xref ref-type="bibr" rid="bib54">Mascher et al., 2007</xref>). Moreover, <italic>sigM</italic> null mutants are highly MOE sensitive (<xref ref-type="bibr" rid="bib54">Mascher et al., 2007</xref>), which suggested that the missing TG might be part of the σ<sup>M</sup> regulon. Indeed, the elongasome-associated TG has been identified as the SEDS family protein RodA (<xref ref-type="bibr" rid="bib57">Meeske et al., 2016</xref>; <xref ref-type="bibr" rid="bib24">Emami et al., 2017</xref>), a known member of the σ<sup>M</sup> regulon (<xref ref-type="bibr" rid="bib23">Eiamphungporn and Helmann, 2008</xref>; <xref ref-type="bibr" rid="bib34">Helmann, 2016</xref>). A RodA paralog, FtsW, provides TG activity in the context of the divisome (<xref ref-type="bibr" rid="bib80">Taguchi et al., 2019</xref>; <xref ref-type="bibr" rid="bib50">Liu et al., 2018</xref>).</p><p>Our current understanding of PG synthesis during cell elongation in <italic>B. subtilis</italic> suggests that the bulk of synthesis is provided by the elongasome, with RodA serving as TG and PBP2a and PbpH, and perhaps also aPBPs, serving as TP (<xref ref-type="bibr" rid="bib24">Emami et al., 2017</xref>; <xref ref-type="bibr" rid="bib57">Meeske et al., 2016</xref>). This action is directional, largely oriented perpendicular to the long cell axis, and is balanced by a more diffusive activity of aPBPs (<xref ref-type="bibr" rid="bib17">Dion et al., 2019</xref>; <xref ref-type="bibr" rid="bib88">Vigouroux et al., 2020</xref>). Cells that rely exclusively on the elongasome for growth are longer and thinner, whereas those that rely predominantly on aPBPs tend to be wider and shorter (<xref ref-type="bibr" rid="bib17">Dion et al., 2019</xref>). Many PG synthesis inhibitors activate the σ<sup>M</sup> regulon, and this leads to elevated expression of many key PG biosynthetic enzymes (MurB, Amj, BcrC), elongasome components (MreB, RodA, MreCD), and the major aPBP (PBP1) (<xref ref-type="bibr" rid="bib23">Eiamphungporn and Helmann, 2008</xref>; <xref ref-type="bibr" rid="bib34">Helmann, 2016</xref>). However, some antibiotics may act selectively on the aPBPs or the elongasome, and it is less clear how cells might act to balance these two biosynthetic activities.</p><p>Here, we sought to define pathways important for fitness in cells that rely exclusively on the elongasome for cell elongation. We demonstrate that cells lacking aPBPs, or even just PBP1 (<italic>ponA</italic>), require a regulatory pathway that selectively increases expression of elongasome-associated proteins. Specifically, <italic>ΔponA</italic> mutant cells are unable to grow in the absence of σ<sup>I</sup>, which induces transcription of genes encoding MreBH and an associated autolysin, LytE. Factors that facilitate σ<sup>I</sup> activity, including the RasP intramembrane peptidase and its regulator EcsAB, are therefore also essential under these conditions. Further support for the importance of MreBH and LytE derives from analysis of a suppressor mutation that activates the WalKR two-component system, and thereby also restores viability to a <italic>ΔrasPΔponA</italic> double mutant by up-regulating these same elongasome components. These results suggest that the σ<sup>I</sup> stress response acting in concert with the WalKR system helps to maintain balanced activity of the elongasome and the aPBPs during cell elongation.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>The EcsAB-RasP pathway is essential in the absence of class A PBPs</title><p>Bacteria often use overlapping or redundant systems to sustain essential pathways such as PG synthesis. To identify genes with significant roles in elongasome activity in <italic>B. subtilis,</italic> we constructed a strain (designated Δ4) lacking all four class A PBPs (aPBPs), and which therefore relies solely on the elongasome for PG synthesis during cell elongation (<xref ref-type="bibr" rid="bib55">McPherson and Popham, 2003</xref>). A Tn-Seq approach was employed to identify genes essential in the Δ4 strain but not in the wild-type (WT) background. We identified the <italic>ecsAB</italic> operon as having numerous mariner transposon insertions in WT, but very few in the Δ4 strain (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). We verified conditional essentiality of <italic>ecsA</italic> by determining the plating efficiency of a clean, unmarked deletion mutant (Δ<italic>ecsA</italic>) in a <italic>ponA</italic> depletion background in the presence and absence of the genes encoding the other 3 aPBPs (<italic>pbpD</italic>, <italic>pbpF</italic>, <italic>pbpG</italic>). Interestingly, <italic>ecsA</italic> was not only essential in the Δ4 background but also with depletion of <italic>ponA</italic> alone (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Mutations that impair PG synthesis can often be rescued by growth on plates amended with 20 mM MgSO<sub>4</sub>, which leads to decreased activity of autolysins and thereby helps restore balance between PG synthesis and degradation pathways (<xref ref-type="bibr" rid="bib25">Formstone and Errington, 2005</xref>). Indeed, an <italic>ΔecsAΔponA</italic> mutant was viable when streaked on high Mg plates, and growth was Mg-dependent (<xref ref-type="fig" rid="fig1">Figure 1B</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>The <italic>ecsA</italic> and <italic>ponA</italic> genes are synthetic lethal in LB medium.</title><p>(<bold>A</bold>) Plating efficiency of <italic>ecsA</italic> deletion mutants. Right panel: spot dilutions were used to assess the effect of an <italic>ecsA</italic> null mutation on growth in a <italic>ponA</italic> depletion background (-IPTG) with and without additional mutations in <italic>pbpD</italic>, <italic>pbpF</italic>, <italic>pbpG</italic> (to mimic the Δ4 A PBP background). Left panel: <italic>ponA</italic> was induced (+IPTG) from the P<sub>spank*</sub> promoter. (<bold>B</bold>) Growth of <italic>ΔecsA</italic>, <italic>ΔrasP</italic>, <italic>ΔponA</italic> and the double mutants <italic>ΔecsAΔponA</italic> and <italic>ΔrasPΔponA</italic> on LB agar plates with and without supplementation with 20 mM MgSO<sub>4</sub>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57902-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Transposon insertion profile of the <italic>ecsAB</italic> operon.</title><p>Representation of TnSeq insertions in a WT and Δ4 aPBP background. Red bars indicate coverage of transposon insertions in the WT background and green bars indicate the same in Δ4 aPBP background. Shown here is a profile of <italic>ecsA</italic> and <italic>ecsB</italic> genes that lack insertions in the Δ4 aPBP strain. In contrast, the genes had insertions at multiple sites in WT strain.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57902-fig1-figsupp1-v1.tif"/></fig></fig-group><p>EcsA has been designated as part of an ABC-type transporter involved in the expression and secretion of proteins (<xref ref-type="bibr" rid="bib48">Leskelä et al., 1999</xref>). Deletion of <italic>ecsA</italic> has a profound effect on the intramembrane protease RasP, with similar phenotypes noted for the <italic>ecsA</italic> and <italic>rasP</italic> deletion mutants (<xref ref-type="bibr" rid="bib33">Heinrich et al., 2008</xref>). Consequently, we tested whether the essential role of EcsA in the <italic>ΔponA</italic> strain was due to RasP. Indeed, viability of <italic>ΔrasPΔponA</italic>, like <italic>ΔecsAΔponA</italic>, depended on high Mg concentrations (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). The above data highlight the importance of the EcsAB-RasP pathway in maintaining viability in the absence of aPBPs.</p></sec><sec id="s2-2"><title>Mutants defective in the EcsAB-RasP pathway are sensitive to antibiotics that inhibit aPBPs</title><p>Upregulation of elongasome activity is known to alleviate aPBP defects (<xref ref-type="bibr" rid="bib57">Meeske et al., 2016</xref>). Based on the observed conditional essentiality, we hypothesized that the EcsAB-RasP pathway might functionally compensate for the absence of aPBPs. As a first test of this hypothesis, we measured sensitivity to moenomycin (MOE), a specific inhibitor of aPBP-associated TG activity (<xref ref-type="bibr" rid="bib86">Van Heijenoort et al., 1978</xref>; <xref ref-type="bibr" rid="bib11">Chen et al., 2019</xref>). Indeed, <italic>ecsA</italic> and <italic>rasP</italic> mutants were MOE sensitive with a four-fold decrease in minimum inhibitory concentration (MIC) relative to WT (<xref ref-type="table" rid="table1">Table 1</xref>). This was not due to a general growth defect: <italic>ecsA</italic> and <italic>rasP</italic> single mutants grew as well as WT in the absence of MOE, albeit with some lysis in stationary phase (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), consistent with previous observations (<xref ref-type="bibr" rid="bib33">Heinrich et al., 2008</xref>). This antibiotic sensitivity could be complemented by ectopic expression of <italic>ecsAB</italic> or <italic>rasP</italic>, respectively (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Moreover, <italic>ΔecsAΔrasP</italic> had a similar MOE sensitivity as <italic>ΔrasP</italic> (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), suggesting that the synthetic lethality of <italic>ecsA</italic> with <italic>ponA</italic> is mediated through its known downstream effect on the activity of RasP (<xref ref-type="bibr" rid="bib33">Heinrich et al., 2008</xref>). In contrast to MOE, the <italic>ΔrasP</italic> and <italic>ΔponA</italic> mutants had a similar sensitivity as WT when tested for sensitivity to antibiotics that act on substrates common to both the elongasome and aPBP-dependent pathways of PG synthesis. For example, both nisin (<xref ref-type="bibr" rid="bib94">Wiedemann et al., 2001</xref>) and vancomycin (<xref ref-type="bibr" rid="bib91">Watanakunakorn, 1984</xref>) bind the common lipid II intermediate (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Together, these results suggest that the EcsAB-RasP pathway is critical when aPBPs are compromised, but not as a general response to inhibition of PG synthesis.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>The EcsAB-RasP pathway is important for intrinsic antibiotic resistance.</title><p>(<bold>A</bold>) Growth kinetics of WT, <italic>ΔecsA</italic>, <italic>ΔrasP</italic> and the <italic>ΔecsAΔrasP</italic> double mutant in liquid LB medium with (dotted lines) and without (continuous lines) 0.4 µg/mL moenomycin (MOE). (<bold>B</bold>) β-lactam sensitivity of <italic>ΔrasP</italic> and <italic>ΔponA</italic> strains determined by disc diffusion assay using cefuroxime (CEF) (10 µg), oxacillin (3 µg), ampicillin (15 µg), and penicillin G (20 units). No comparison was done between antibiotic groups. P-value cutoff of &lt;0.001 was used.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Data of growth kinetics and zone of inhibition.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57902-fig2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57902-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Antibiotic susceptibility of <italic>ΔecsA</italic> and <italic>ΔrasP</italic> mutants.</title><p>(<bold>A</bold>) Growth kinetics of WT, <italic>ΔecsA</italic>, <italic>ΔecsA-P<sub>spac(hy)</sub>ecsA</italic>, <italic>ΔecsA P<sub>spac(hy)</sub>ecsAecsB</italic>, <italic>ΔrasP</italic> and <italic>ΔrasP-P<sub>spac(hy)</sub>rasP</italic> in LB medium supplemented with 1 µg/mL MOE and 0.25 mM IPTG for inducing the ectopic copies of <italic>ecsA/ecsB</italic> and <italic>rasP</italic>. (<bold>B</bold>) Disc diffusion assay for screening WT, <italic>ΔrasP</italic> and <italic>ΔponA</italic> strains for their sensitivity towards nisin and vancomycin; antibiotics which can affect the activity of both the aPBPs and the elongasome. No comparison was done between antibiotic groups. P-value cutoff of &lt;0.0001 was used.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57902-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Synergistic interaction of MOE and CEF in <italic>B. subtilis</italic>.</title><p>Growth kinetics of WT treated with (<bold>A</bold>) MOE (0.2–3.2 µg/mL) (<bold>B</bold>) CEF (0.02–5.12 µg/mL) and (<bold>C–E</bold>) combination of MOE at 0.2 µg/mL, 0.4 µg/mL and 0.8 µg/mL with a range of CEF concentration (0.02–5.12 µg/mL) (<bold>F</bold>) A table for the Fractional Inhibitory Concentration (FIC) index for the combinatorial treatment of MOE and CEF. FIC index was calculated using the formula mentioned in <xref ref-type="bibr" rid="bib29">Hall et al., 1983</xref>. A FIC index value of ≤0.5 is considered as a synergistic interaction (<xref ref-type="bibr" rid="bib60">Odds, 2003</xref>). MIC of each drug individually or in combination was defined based on significant growth inhibition up to at least 10 hr of treatment.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57902-fig2-figsupp2-v1.tif"/></fig></fig-group><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Minimum inhibitory concentration (MIC) of various strains for moenomycin in µg/mL.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Strains</th><th valign="top">Moenomycin MIC (µg/mL)</th></tr></thead><tbody><tr><td valign="top"><italic>WT</italic></td><td valign="top">1.6</td></tr><tr><td valign="top"><italic>ΔecsA</italic></td><td valign="top">0.4</td></tr><tr><td valign="top"><italic>ΔrasP</italic></td><td valign="top">0.4</td></tr><tr><td valign="top"><italic>ΔponA</italic></td><td valign="top">&gt;1.6</td></tr><tr><td valign="top"><italic>ΔsigW</italic></td><td valign="top">1.6</td></tr><tr><td valign="top"><italic>ΔsigV</italic></td><td valign="top">1.6</td></tr><tr><td valign="top"><italic>ΔsigI</italic></td><td valign="top">0.4</td></tr><tr><td valign="top"><italic>Δ25ftsL</italic></td><td valign="top">1.6</td></tr></tbody></table></table-wrap><p>We next sought to test antibiotics that, unlike MOE, inhibit aPBPs at their TP active site. We reasoned that a stress response important for elongasome activity should also provide resistance to antibiotics that inhibit aPBPs, assuming they do not also interfere with the bPBPs essential for the elongasome. We tested 4 β-lactams (cefuroxime, oxacillin, ampicillin and penicillin G) for their inhibition profiles against <italic>ΔrasP</italic> and <italic>ΔponA</italic> strains. Oxacillin and cefuroxime (CEF) were previously suggested to preferentially inhibit aPBPs (<xref ref-type="bibr" rid="bib71">Sassine et al., 2017</xref>; <xref ref-type="bibr" rid="bib76">Sharifzadeh et al., 2020</xref>), whereas penicillin G preferentially inhibits bPBPs (<xref ref-type="bibr" rid="bib71">Sassine et al., 2017</xref>). Consistently, oxacillin and CEF had highest activity against ∆<italic>rasP</italic>, whereas penicillin G and ampicillin had the highest activity against ∆<italic>ponA,</italic> which encodes the major aPBP, PBP1 (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). These results support the idea that the EcsAB-RasP pathway functionally compensates either for the absence of aPBPs or for their chemical inhibition at either the TG (MOE) or TP (CEF) active sites.</p><p>Interestingly, the ∆<italic>ponA</italic> mutant was actually more CEF resistant than WT. Thus, PBP1 inactivated by CEF may be deleterious to the cell. This is suggestive of futile cycling, a process in which inactivation of the TP active site leads to an ongoing generation and degradation of uncrosslinked PG strands driven by the aPBP-associated TG (<xref ref-type="bibr" rid="bib12">Cho et al., 2014</xref>; <xref ref-type="bibr" rid="bib92">Waxman et al., 1980</xref>). To explore this idea further, we treated WT cells with sub-inhibitory concentrations of two drugs simultaneously, MOE and CEF, that inhibit the two different active sites of the aPBP proteins. If CEF results in futile cycling, we reasoned that MOE might antagonize this effect. In contrast, MOE and CEF together resulted in synergistic inhibition (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). This is consistent with the <italic>same target drug synergy model</italic>, as previously described for <italic>E. coli</italic> protein synthesis inhibitors (<xref ref-type="bibr" rid="bib95">Yilancioglu, 2019</xref>) and drugs used to treat human diseases (<xref ref-type="bibr" rid="bib37">Jia et al., 2009</xref>), but does not support the hypothesis of CEF-dependent futile cycling.</p></sec><sec id="s2-3"><title>EcsAB-RasP functions through σ<sup>I</sup> to sustain cell wall synthesis in the absence of aPBPs</title><p>RasP functions as an intramembrane protease for the activation of multiple stress response pathways, and our results suggest it may be important for PG synthesis when aPBPs are missing or inhibited. RasP proteolytically inactivates the anti-sigma factors RsiW (regulator of σ<sup>W</sup>) (<xref ref-type="bibr" rid="bib74">Schöbel et al., 2004</xref>), RsiV (regulator of σ<sup>V</sup>) (<xref ref-type="bibr" rid="bib31">Hastie et al., 2013</xref>) and RsgI (regulator of σ<sup>I</sup>) (<xref ref-type="bibr" rid="bib49">Liu et al., 2017</xref>). In the absence of RasP, these σ factors can not be activated. RasP also cleaves FtsL, a cell division protein (<xref ref-type="bibr" rid="bib5">Bramkamp et al., 2006</xref>). To determine which of these RasP targets may contribute to elongasome activity, we took advantage of the fact that MOE and CEF selectively inactivate aPBPs. Therefore, MOE and CEF resistance provides a readout of elongasome function. We tested mutants lacking each of the three RasP-dependent sigma factors or containing Δ25FtsL, coding for a functional, but truncated FtsL (deleted in amino acids 2–26) variant that is not subject to cleavage by RasP (<xref ref-type="bibr" rid="bib5">Bramkamp et al., 2006</xref>). The <italic>ΔecsA</italic> and <italic>ΔrasP</italic> mutants were 4-fold more sensitive to MOE than WT (0.4 vs. 1.6 µg/mL), whereas for <italic>ΔponA</italic> the (MIC) was &gt;1.6 µg/mL (<xref ref-type="table" rid="table1">Table 1</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). The MIC was unaffected by deletion of <italic>sigW</italic> or <italic>sigV</italic> or by the non-cleavable FtsL (1.6 µg/mL). However, the <italic>ΔsigI</italic> mutant was significantly more sensitive to MOE with the MIC being 0.4 µg/mL, similar to <italic>ΔrasP</italic>. This suggests that σ<sup>I</sup> is required for optimal function of the MOE-insensitive elongasome.</p><p>Similar results were observed when CEF sensitivity was monitored (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Of the known RasP targets, σ<sup>I</sup> contributes the most to CEF resistance. Moreover, the <italic>ΔsigWΔsigI</italic> mutant phenocopies the <italic>ΔrasP</italic> mutant, suggesting that activation of σ<sup>I</sup> and σ<sup>W</sup> largely accounts for the role of RasP in CEF resistance. In addition, the sensitivity of the <italic>ΔecsA</italic> and <italic>ΔrasP</italic> mutants was not further increased by mutation of <italic>sigW</italic> or <italic>sigI</italic> (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>), indicative of them being in the same pathway. Finally, deletion of <italic>rsgI</italic>, encoding the σ<sup>I</sup> anti-sigma factor, led to a significant decrease in CEF sensitivity of the <italic>ΔecsA</italic> and <italic>ΔrasP</italic> mutants. <italic>ΔrsgI</italic> was more sensitive to CEF compared to WT, which may be due to increased activity of σ<sup>I</sup> and its associated autolysins. In contrast, deletion of <italic>rsiW</italic>, encoding the σ<sup>W</sup> anti-sigma factor, led to a much less pronounced effect (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). Thus, σ<sup>I</sup> plays a dominant role in intrinsic CEF resistance, and as expected this activity relies on the RasP-dependent degradation of the RsgI anti-sigma factor.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>The EcsAB-RasP pathway functions largely through <italic>sigI</italic>.</title><p>(<bold>A</bold>) CEF (10 µg) sensitivity (disc diffusion assay) for WT, <italic>ΔrasP</italic>, <italic>ΔsigV</italic>, <italic>ΔsigW</italic>, <italic>Δ25ftsL</italic>, <italic>ΔsigI</italic>, <italic>ΔsigWΔsigI</italic> and <italic>ΔsigVΔsigWΔ25ftsLΔsigI</italic> strains. P-value cut-off of &lt;0.0001 was used. (<bold>B</bold>) Plating efficiency of <italic>ΔrasP</italic>, <italic>ΔsigI</italic> and <italic>ΔsigVΔsigWΔ25ftsL</italic> strains in WT and <italic>ΔponA</italic> deletion background. This assay was done by plating 10 µL of mid-log phase cultures (grown in LB with 20 mM MgSO<sub>4</sub>) on LB agar plates (no Mg supplementation). The plating efficiency of <italic>ΔsigIΔponA</italic> double mutant was also evaluated after ectopic expression of <italic>sigI</italic> from the leaky promoter P<sub>spac(hy)</sub>.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Data of zone of inhibition.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57902-fig3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57902-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>σ<sup>I</sup> and RasP have similar MIC against MOE.</title><p>Growth kinetics of WT, <italic>ΔecsA</italic>, <italic>ΔrasP, ΔponA, ΔsigW, ΔsigV, ΔsigI, Δ25ftsL</italic> in the presence of 0, 0.2, 0.4, 0.8, 1.6 µg/mL MOE in LB medium. The concentration of the drug which inhibited growth up to at least 10 hr of treatment was considered as the MIC of the drug against the respective strain.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57902-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>RasP functions primarily through σ<sup>I</sup> to provide resistance against CEF.</title><p>Disc diffusion assay for CEF (10 µg) against (<bold>A</bold>) <italic>ΔecsA</italic> and <italic>ΔrasP</italic> in combination with the deletion mutants of <italic>ΔsigI</italic> and <italic>ΔsigW</italic> (<bold>B</bold>) <italic>ΔecsA</italic> and <italic>ΔrasP</italic> in combination with the deletion mutants of the anti-sigma factors <italic>ΔrsgI</italic> and <italic>ΔrsiW.</italic> P-value cut-off of 0.0001 was used.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57902-fig3-figsupp2-v1.tif"/></fig></fig-group><p>The importance of σ<sup>I</sup> in the absence of aPBPs was confirmed by determining the plating efficiency of <italic>ΔsigIΔponA</italic> double mutant (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). The double mutant could survive with high Mg<sup>2+</sup>, but was unable to grow on LB. This synthetic lethality of the <italic>ΔsigIΔponA</italic> and <italic>ΔrasPΔponA</italic> strains was suppressed by ectopically expressing the <italic>sigI</italic> gene from the leaky promoter P<sub>spac(hy)</sub>. Thus, decreased σ<sup>I</sup> activity can fully explain the ∆<italic>rasP</italic> antibiotic sensitivity phenotypes, and we therefore conclude that one or more members of the σ<sup>I</sup> regulon must facilitate growth under conditions of impaired aPBP activity.</p></sec><sec id="s2-4"><title>σ<sup>I</sup> supports elongasome function by regulating MreBH and LytE</title><p>Next, we sought to identify the σ<sup>I</sup>-dependent genes important for survival in the absence of aPBPs. Of the genes directly regulated by σ<sup>I</sup> (<xref ref-type="bibr" rid="bib66">Ramaniuk et al., 2018</xref>), five (<italic>mreBH</italic>, <italic>lytE</italic>, <italic>gsiB</italic>, <italic>fabI</italic> and <italic>bcrC)</italic> have known or likely roles related to cell envelope functions. GsiB is a general stress response protein (<xref ref-type="bibr" rid="bib58">Michna et al., 2016</xref>) and FabI is involved in fatty acid synthesis (<xref ref-type="bibr" rid="bib32">Heath et al., 2000</xref>). BcrC functions in undecaprenylpyrophosphate recycling (<xref ref-type="bibr" rid="bib3">Bernard et al., 2005</xref>; <xref ref-type="bibr" rid="bib96">Zhao et al., 2016</xref>; <xref ref-type="bibr" rid="bib65">Radeck et al., 2017b</xref>), and MreBH and LytE are both elongasome-associated proteins. MreBH, one of three MreB-family proteins that associate with the elongasome, sequesters and directs the LytE endopeptidase to the sites of insertion of new peptidoglycan (<xref ref-type="bibr" rid="bib9">Carballido-López et al., 2006</xref>). To further define the role of σ<sup>I</sup> in sustaining viability during aPBP inhibition, we conducted CEF/MOE sensitivity assays using single mutants of σ<sup>I</sup>-controlled genes. The <italic>mreBH</italic>, <italic>lytE</italic> and <italic>bcrC</italic> single mutants exhibited slightly higher sensitivity for both CEF and MOE (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>), however, they did not entirely phenocopy the <italic>sigI</italic> phenotype. The <italic>ΔmreBHΔlytE</italic> double mutant exhibited the same level of CEF and MOE sensitivity as both the <italic>rasP</italic> and <italic>sigI</italic> mutants (<xref ref-type="fig" rid="fig4">Figure 4A–B</xref>). Thus, these results suggest that the EcsAB-RasP-σ<sup>I</sup> pathway primarily acts through MreBH and LytE to control elongasome function.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>σ<sup>I</sup> functions by increasing expression of <italic>mreBH</italic> and <italic>lytE</italic>.</title><p>(<bold>A</bold>) CEF (10 µg) sensitivity (disc diffusion assay) of <italic>ΔmreBH</italic>, <italic>ΔlytE</italic> and <italic>ΔmreBHΔlytE</italic> strains. Significance was determined with a P-value cut-off of &lt;0.0001. (<bold>B</bold>) Growth kinetics of the mutants in LB medium with 1 µg/mL MOE. (<bold>C</bold>) Plating efficiency of the <italic>ΔmreBH, ΔlytE,</italic> and <italic>ΔmreBHΔlytE</italic> mutants alone and in combination with <italic>ΔponA</italic>. (<bold>D</bold>) The autolytic potential of the cells (WT, <italic>ΔponA</italic>, <italic>ΔrasP</italic>, <italic>ΔsigI</italic>, <italic>ΔmreBH</italic>, <italic>ΔlytE</italic> and <italic>ΔsigVΔsigWΔ25ftsL</italic>) measured by the time taken to reach 50% of initial cell density on treatment with sodium azide. P-value cut-off of &lt;0.0001 was used. (<bold>E</bold>) Gene expression values (2<sup>-Δct</sup>) of <italic>mreBH</italic> and <italic>lytE</italic> normalized to <italic>gyrA</italic> plotted on log<sub>10</sub> scale for WT, <italic>ΔrasP</italic>, <italic>ΔsigI</italic> and <italic>ΔponA</italic> strains.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Data of zone of inhibition, MOE growth kinetics, lysis time and gene expression.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57902-fig4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57902-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>σ<sup>I</sup> regulates the expression of <italic>mreBH</italic> and <italic>lytE</italic> to support elongasome function.</title><p>The importance of the σ<sup>I</sup> regulon genes (<italic>mreBH, lytE, gsiB, fabI, bcrC</italic>) in the absence of <italic>ponA</italic> determined by the (<bold>A</bold>) Disc diffusion assay for CEF (10 µg). P-value cut-off of 0.0001 was used. (<bold>B</bold>) Growth kinetics in the presence of LB medium supplemented with 1 µg/mL MOE. (<bold>C</bold>) Transformation images of <italic>rasP::kan</italic> gDNA in <italic>ΔlytE</italic> and <italic>ΔcwlO</italic> background. <italic>ponA::erm</italic> transformation carried out as a control in <italic>ΔcwlO</italic> background. It validates that the transformation efficiency of the <italic>ΔcwlO</italic> strain was not compromised.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57902-fig4-figsupp1-v1.tif"/></fig></fig-group><p>To further validate the importance of MreBH and LytE, we created deletion mutants in the <italic>ΔponA</italic> background (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). A <italic>ΔmreBHΔponA</italic> double mutant could be constructed only when the cells were initially plated on LB supplemented with high Mg<sup>2+</sup>. Once constructed, however, this mutant and the <italic>ΔlytEΔponA</italic> double mutant did not exhibit a plating defect on LB. In contrast, the triple mutant of <italic>ΔmreBHΔlytEΔponA</italic> was synthetic lethal and could not be plated on LB agar without Mg<sup>2+</sup> supplementation. These data suggest an additive role for MreBH and LytE in the effective functioning of the elongasome, likely due to the ability of LytE to retain some function in the absence of MreBH, and MreBH having functional roles beyond localization of LytE.</p><p><italic>B. subtilis</italic> has two partially redundant D,L-endopeptidases, LytE and CwlO, which are collectively essential for cell viability (<xref ref-type="bibr" rid="bib30">Hashimoto et al., 2012</xref>). The involvement of σ<sup>I</sup> in the expression of <italic>lytE</italic> has already been established since both <italic>ΔlytEΔcwlO</italic> and <italic>ΔsigIΔcwlO</italic> are synthetic lethal (<xref ref-type="bibr" rid="bib70">Salzberg et al., 2013</xref>). Consistently, <italic>ΔrasPΔcwlO</italic> was also synthetic lethal (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). To confirm that LytE activity was reduced in the <italic>rasP</italic> and <italic>sigI</italic> mutants we evaluated the autolytic potential of the cells. Cells were treated with sodium azide, which disrupts membrane potential and activates autolysins (<xref ref-type="bibr" rid="bib38">Jolliffe et al., 1981</xref>; <xref ref-type="bibr" rid="bib90">Wang et al., 2014</xref>). By monitoring the time taken for a 50% reduction in optical density, we found that the <italic>ΔlytE</italic> mutant had a lower rate of autolysis (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Similar to <italic>ΔlytE</italic>, we observed that <italic>ΔrasP</italic>, <italic>ΔsigI</italic> and <italic>ΔmreBH</italic> also had lower autolytic potential, consistent with a role in affecting LytE expression or activity.</p><p>Next, we evaluated the expression levels of <italic>mreBH</italic> and <italic>lytE</italic> in <italic>ΔrasP</italic>, <italic>ΔsigI</italic> and <italic>ΔponA</italic> mutants (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). In the <italic>ΔponA</italic> mutant, <italic>mreBH</italic> was significantly upregulated, whereas <italic>lytE</italic> was unchanged. In <italic>ΔsigI</italic>, both <italic>mreBH</italic> and <italic>lytE</italic> expression was significantly lower. This suggests that <italic>ΔponA</italic> cells require higher levels of MreBH to direct the autolytic activity of LytE to support optimal elongasome function, and that activation of σ<sup>I</sup> mediates increased <italic>mreBH</italic> expression. As a result, the reduced expression of <italic>mreBH</italic> in <italic>ΔrasP</italic> and <italic>ΔsigI</italic> strains likely contributes to the synthetic lethality with <italic>ΔponA</italic>.</p></sec><sec id="s2-5"><title>Balance in the MreBH-LytE activity is essential for optimal elongasome function</title><p>We complemented the conditional essentiality of <italic>mreBH</italic> and <italic>lytE</italic> by ectopically expressing each of these genes individually as well as in combination in different mutant backgrounds. These strains were used to evaluate the relative importance of each gene upon inhibition of PBP1 by monitoring their CEF resistance. Although ectopic expression of <italic>mreBH</italic> complements the CEF sensitivity of <italic>ΔmreBH</italic>, it is unable to restore CEF resistance to the <italic>ΔmreBHΔlytE</italic> double mutant (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). However, when both <italic>mreBH</italic> and <italic>lytE</italic> were ectopically expressed, the strain was significantly more CEF resistant than WT (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Similarly, induction of <italic>mreBH</italic> modestly increased CEF resistance of <italic>ΔrasP</italic> (<xref ref-type="fig" rid="fig5">Figure 5B</xref>), but not a <italic>ΔrasPΔlytE</italic> double mutant. Similar results were obtained in cells where <italic>pbpD, pbpF and pbpG</italic> were deleted (data not shown) indicating no indirect effect of MreBH on these aPBPs. In <italic>ΔsigI,</italic> however, <italic>mreBH</italic> expression alone had no significant impact on CEF resistance, perhaps due to reduced availability of LytE. Thus, increasing MreBH levels likely functions to increase elongasome activity by facilitating the localized action of LytE. Conversely, the <italic>P<sub>spac(hy)</sub>lytE</italic> overexpression construct could not be introduced into the <italic>ΔrasP</italic> and <italic>ΔsigI</italic> mutants. We speculate that high LytE, in cells that have reduced expression of <italic>mreBH</italic>, leads to delocalized and unregulated autolysin activity. Collectively, these results further support a model in which a major role of MreBH is in directing LytE to sites of ongoing, elongasome-dependent PG synthesis.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>MreBH and LytE function cooperatively to increase elongasome function.</title><p>(<bold>A</bold>) CEF (10 µg) sensitivity (disc diffusion assay) of the <italic>ΔmreBH</italic>, <italic>ΔlytE,</italic> and <italic>ΔmreBHΔlytE</italic> strains with and complementation by ectopic expression of genes from the leaky promoter, P<sub>spac(hy)</sub>, or (for the <italic>ΔmreBHΔlytE</italic> strain) expression of <italic>mreBH</italic> from a xylose inducible promoter (P<sub>xyl</sub>) and <italic>lytE</italic> from the P<sub>spac(hy)</sub>. P-value cut-off of &lt;0.0001 was used. (<bold>B</bold>) CEF sensitivity (as for panel A) for <italic>ΔrasP</italic> and <italic>ΔsigI</italic> mutants with ectopic expression of <italic>mreBH</italic> from P<sub>spac(hy)</sub> in the presence and absence of <italic>lytE</italic>. P-value cut-off of &lt;0.0001 was used. Cell length (<bold>C</bold>) and width (<bold>D</bold>) of WT, <italic>ΔponA</italic>, <italic>ΔrasP</italic>, <italic>ΔsigI</italic>, <italic>ΔmreBHΔlytE</italic>, and <italic>ΔmreBH and ΔlytE</italic> strains was determined using at least 100 cells for each strain. P-value cut-off of &lt;0.005 was used.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Data of zone of inhibition and cell size measurements.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57902-fig5-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57902-fig5-v1.tif"/></fig><p>The elongasome is critical for the maintenance of rod-shape, as judged by the spherical morphology of conditional mutants that are depleted for either the RodA transglycosylase or the two class B PBPs that provide transpeptidase activity (<xref ref-type="bibr" rid="bib4">Boylan and Mendelson, 1969</xref>; <xref ref-type="bibr" rid="bib93">Wei et al., 2003</xref>). The maintenance of rod shape is also affected by the balance between the directional motion of the elongasome and the random diffusive motion of PBP1 (<xref ref-type="bibr" rid="bib17">Dion et al., 2019</xref>). Any imbalance in the activities of the two systems can lead to change in cell morphology. Overexpression of MreB or other elongasome proteins leads to cells that are longer and thinner, whereas overexpression of PBP1 leads to shorter and wider cells (<xref ref-type="bibr" rid="bib17">Dion et al., 2019</xref>). Thus, we hypothesized that the effects of the σ<sup>I</sup> regulatory system (acting through <italic>mreBH</italic> and <italic>lytE</italic>) on elongasome function would be revealed by monitoring cell morphology. We imaged WT, <italic>ΔrasP</italic>, <italic>ΔsigI</italic>, <italic>ΔmreBH, ΔlytE, ΔmreBHΔlytE</italic> and <italic>ΔponA</italic> cells and quantified the cell length and width using MicrobeJ (<xref ref-type="bibr" rid="bib21">Ducret et al., 2016</xref>). Indeed, <italic>ΔrasP</italic>, <italic>ΔsigI</italic> and <italic>ΔmreBHΔlytE</italic> mutants were significantly shorter (<xref ref-type="fig" rid="fig5">Figure 5C</xref>) and wider (<xref ref-type="fig" rid="fig5">Figure 5D</xref>) compared to the WT, which indicates that these cells were primarily utilizing PBP1 for PG synthesis. <italic>ΔmreBH and ΔlytE</italic> mutants individually also had lower elongasome activity. In contrast, the <italic>ΔponA</italic> mutant formed significantly thinner cells due to PG synthesis being contributed mainly by the elongasome. These data support the conclusion that the <italic>rasP</italic>, <italic>sigI</italic> and <italic>mreBH-lytE</italic> genes all support elongasome function.</p></sec><sec id="s2-6"><title>Suppressor analysis confirms the importance of <italic>mreBH</italic> and <italic>lytE</italic> in cells dependent on elongasome</title><p>Next, we took advantage of the <italic>ΔrasPΔponA</italic> synthetic lethality to isolate suppressors that grow on LB agar plates. Using whole-genome resequencing, we identified three strains with point mutations in <italic>walK</italic> (Ala241Asp, Ser385Leu, Asp274Ala). WalK is the sensor kinase of the essential two-component system WalKR, which regulates cell wall metabolism (<xref ref-type="bibr" rid="bib81">Takada and Yoshikawa, 2018</xref>). WalR has binding sites upstream of <italic>sigI</italic>, <italic>mreBH</italic> and <italic>lytE</italic> and activates expression of these genes under heat stress (<xref ref-type="bibr" rid="bib36">Huang et al., 2013</xref>). In addition to their regulation by σ<sup>I</sup><italic>, sigI</italic> and <italic>lytE</italic> also have σ<sup>A</sup>-dependent promoters. WalR may function in conjunction with the σ<sup>A</sup> holoenzyme, which together with σ<sup>I</sup> controls <italic>lytE</italic> expression (<xref ref-type="bibr" rid="bib84">Tseng et al., 2011</xref>). Taking into account the importance of WalKR in the expression of <italic>sigI</italic>, <italic>mreBH</italic> and <italic>lytE</italic>, we characterized one of the suppressor mutants of WalK, wherein aspartate 274 is changed to alanine (D274A).</p><p>Residue 274 lies in the cytoplasmic Per-Arnt-Sim (PAS) domain of WalK (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). PAS domains have been linked to signal sensing (<xref ref-type="bibr" rid="bib82">Taylor and Zhulin, 1999</xref>) and may be involved in protein dimerization (<xref ref-type="bibr" rid="bib35">Huang et al., 1993</xref>). Recently, the cytoplasmic PAS domain of <italic>S. aureus</italic> WalK was found to bind zinc at a site including D274. Moreover, mutation in this binding site, which is highly conserved in WalK orthologs (<xref ref-type="bibr" rid="bib59">Monk et al., 2019</xref>), led to increased kinase activity. We therefore hypothesized that the WalK<sup>D274A</sup> suppressor (denoted as WalK*) led to increased activity of the WalKR two-component system. We used CRISPR mutagenesis to introduce the <italic>walK</italic>* allele into WT cells and then confirmed that this allele suppressed the synthetic lethality of <italic>ΔrasPΔponA</italic> (<xref ref-type="fig" rid="fig6">Figure 6B</xref>).</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>A <italic>walK</italic>* suppressor mutation elevates <italic>mreBH</italic> transcription.</title><p>(<bold>A</bold>) The D274 residue of WalK is part of a PAS-domain associated Zn-binding motif. (<bold>B</bold>) A <italic>walK*</italic> mutation rescues growth of the <italic>ΔrasPΔponA</italic> strain as monitored by a spot dilution assay. (<bold>C</bold>) CEF (10 µg) resistance (disc diffusion assay) of <italic>ΔrasP</italic> and <italic>ΔsigI</italic> and the respective double mutants of <italic>walK*ΔrasP</italic> and <italic>walK*sigI</italic>. A P-value cut-off of &lt;0.0001 was used. (<bold>D</bold>) The effect of <italic>walK*</italic> on the expression profile of <italic>mreBH</italic> and <italic>lytE</italic> genes, alone and in combination with <italic>ΔrasP</italic> and <italic>ΔsigI</italic>. The gene expression values (2<sup>-Δct</sup>) were normalized with the house-keeping gene <italic>gyrA</italic> and then plotted on a log<sub>10</sub> scale.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Data of zone of inhibition and gene expression.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57902-fig6-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57902-fig6-v1.tif"/></fig><p>We next aimed to test the effect of WalK<sup>*</sup> on gene expression and cell wall homeostasis. The <italic>sigI</italic> and <italic>lytE</italic> genes can be expressed through their σ<sup>A</sup> promoter after activation by WalR (<xref ref-type="bibr" rid="bib70">Salzberg et al., 2013</xref>; <xref ref-type="bibr" rid="bib84">Tseng et al., 2011</xref>). However, <italic>mreBH</italic> lacks an annotated σ<sup>A</sup> promoter, implying that the expression of <italic>mreBH</italic> may rely on WalR activation of the σ<sup>I</sup> holoenzyme. To test this hypothesis, we measured CEF sensitivity of <italic>walK*ΔrasP</italic> and <italic>walK*ΔsigI</italic> strains (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). Although <italic>walK*</italic> increased CEF resistance of the <italic>ΔrasP</italic> strain, it could not rescue the <italic>ΔsigI</italic> strain. This supports the idea that WalR may act in conjunction with σ<sup>I</sup> to activate transcription of <italic>mreBH</italic>, and thereby augment elongasome activity. Increased activation of WalK* can lead to increased expression of not only <italic>lytE</italic>, but also <italic>cwlO</italic> (<xref ref-type="bibr" rid="bib81">Takada and Yoshikawa, 2018</xref>). This could lead to elevated autolysin levels that might account for the higher CEF sensitivity of <italic>walK*</italic> alone compared to WT.</p><p>We further quantified the mRNA levels of <italic>mreBH</italic> and <italic>lytE</italic> in the <italic>walK*</italic> strain and in the <italic>walK*ΔrasP</italic> and <italic>walK*ΔsigI</italic> strains (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). The <italic>walK*</italic> allele led to increased expression of both <italic>mreBH</italic> and <italic>lytE</italic>. Moreover, these levels were similar to that observed in the <italic>ΔponA</italic> background, suggesting that deletion of <italic>ponA</italic> leads to a compensatory increase in <italic>mreBH</italic> and <italic>lytE</italic> mediated by the WalKR. However, they were lower for the <italic>walK*ΔsigI</italic> strain. These data suggest that <italic>walK*</italic> leads to increased activation of WalR, which then leads to increased transcription of <italic>sigI</italic> and thereby of <italic>mreBH</italic> and <italic>lytE</italic>. This ultimately leads to the survival of the <italic>ΔrasPΔponA</italic> strain. These data also validate the importance of RasP and σ<sup>I</sup> in the regulation of MreBH and LytE and their significant impact on elongasome activity, especially in the <italic>ΔponA</italic> background.</p></sec><sec id="s2-7"><title>Additive role of σ<sup>I</sup> and σ<sup>M</sup> in regulating the elongasome activity</title><p>While our results suggest a critical role for σ<sup>I</sup> in aPBP-elongasome homeostasis through its regulation of MreBH and LytE, previous studies have indicated that the extracytoplasmic (ECF) sigma factor σ<sup>M</sup> also plays a significant role in <italic>B. subtilis</italic> cell wall homeostasis. σ<sup>M</sup> regulates the expression of <italic>rodA, mreB, mreC</italic> and <italic>mreD</italic> (core components of the elongasome), as well as <italic>ponA</italic> and other genes involved in PG synthesis (<xref ref-type="bibr" rid="bib23">Eiamphungporn and Helmann, 2008</xref>; <xref ref-type="bibr" rid="bib51">Luo and Helmann, 2012</xref>). To determine the relative contribution of σ<sup>M</sup> to cell survival during aPBP inhibition, we used P<sub>M</sub>* mutations that selectively inactivate σ<sup>M</sup>-dependent promoters of genes encoding elongasome components. We constructed the <italic>P<sub>M</sub>*rodA</italic> and <italic>P<sub>M</sub>*ponA</italic> strains that are unable to upregulate <italic>rodA</italic> and <italic>ponA</italic>, respectively, and a <italic>P<sub>M</sub>*maf</italic> strain that cannot upregulate the <italic>mreBCD</italic> genes located downstream of the intragenic <italic>P<sub>M</sub></italic> inside <italic>maf</italic> (<xref ref-type="bibr" rid="bib23">Eiamphungporn and Helmann, 2008</xref>). We also constructed the double mutant <italic>P<sub>M</sub>*rodA P<sub>M</sub>*maf</italic> strain. The CEF sensitivity of <italic>P<sub>M</sub>*rodA</italic> and <italic>P<sub>M</sub>*rodA-P<sub>M</sub>*maf</italic> was similar to that of the <italic>sigM</italic> mutant (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). Neither <italic>P<sub>M</sub>*maf</italic> nor <italic>P<sub>M</sub>*ponA</italic> were CEF sensitive. Thus, under conditions where CEF has inhibited PBP1, σ<sup>M</sup> helps restore peptidoglycan synthesis primarily by increasing the expression of <italic>rodA</italic> to increase elongasome activity. In contrast, the double mutants of <italic>ΔecsAΔsigM, ΔrasPΔsigM</italic> and <italic>ΔsigIΔsigM</italic> revealed an additive effect with respect to CEF sensitivity (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). Thus, the role of the elongasome in PG synthesis can be regulated through two-independent pathways: the EcsAB-RasP-σ<sup>I</sup> pathway acts by regulating MreBH and LytE, and the σ<sup>M</sup> pathway acts through RodA.</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>σ<sup>M</sup> contributes additively with σ<sup>I</sup> to CEF resistance by increasing expression of <italic>rodA</italic>.</title><p>CEF (10 µg) sensitivity (disc diffusion assay) for (<bold>A</bold>) WT, <italic>ΔsigM</italic> and promoter mutants of <italic>P<sub>M</sub>*rodA</italic>, <italic>P<sub>M</sub>*maf</italic> (which controls expression of <italic>mreBCD</italic>), <italic>P<sub>M</sub>*rodA-P<sub>M</sub>*maf</italic> and <italic>P<sub>M</sub>*ponA</italic> and (<bold>B</bold>) WT and <italic>ΔsigM</italic> mutants, alone and in combination with <italic>ΔecsA, ΔrasP</italic> and <italic>ΔsigI</italic>. P-value cut-off of &lt;0.0001 was used for both the graphs.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Data of zone of inhibition.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57902-fig7-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57902-fig7-v1.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Peptidoglycan (PG) is a defining feature of bacteria. This cellular enclosure must provide stability, yet at the same time be highly dynamic and adaptable. During growth, PG is continuously remodeled, which involves the action of autolysins, hydrolytic enzymes that cleave links within and between the glycan strands (<xref ref-type="bibr" rid="bib89">Vollmer et al., 2008</xref>; <xref ref-type="bibr" rid="bib22">Egan et al., 2020</xref>). These hydrolases are essential for the insertion of new glycan strands into the existing structure (<xref ref-type="bibr" rid="bib30">Hashimoto et al., 2012</xref>; <xref ref-type="bibr" rid="bib77">Singh et al., 2012</xref>). Cell shape maintenance requires that the sites of new PG synthesis be spatially regulated, often in response to the activity of cytoskeletal filaments such as the MreB (<xref ref-type="bibr" rid="bib20">Domínguez-Escobar et al., 2011</xref>) and FtsZ proteins (<xref ref-type="bibr" rid="bib53">Mahone and Goley, 2020</xref>).</p><p><italic>B. subtilis</italic>, a genetically tractable model organism, has provided an important system for investigating the pathways of PG synthesis in rod-shaped, Gram positive bacteria. During cell elongation, a multiprotein complex designated the elongasome is the primary biosynthetic machine for inserting new glycan strands. In <italic>B. subtilis</italic>, there are three MreB paralogs (MreB, Mbl and MreBH), which colocalize to form elongasome-associated cytoskeletal filaments along the cell periphery (<xref ref-type="bibr" rid="bib9">Carballido-López et al., 2006</xref>; <xref ref-type="bibr" rid="bib27">Garner et al., 2011</xref>). Cells lacking all three paralogs lose their rod shape and become spheres which ultimately lyse (<xref ref-type="bibr" rid="bib40">Kawai et al., 2009</xref>). Whereas MreB and Mbl are critical for the circumferential motion of the elongasome, the role of MreBH is less clear, and seems related to its ability to recruit LytE (<xref ref-type="bibr" rid="bib9">Carballido-López et al., 2006</xref>). PG synthesis by the elongasome relies on the activity of RodA as TG, with bPBPs providing TP activity (<xref ref-type="fig" rid="fig8">Figure 8A</xref>). A separate complex, the divisome, builds the cross-walls prior to cell separation (<xref ref-type="bibr" rid="bib53">Mahone and Goley, 2020</xref>).</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>σ<sup>I</sup> co-ordinates with WalKR to regulate elongasome function, and complements the σ<sup>M</sup> dependent stress response.</title><p>(<bold>A</bold>) PG synthesis potential is dictated by the activity of the elongasome in collaboration with aPBPs. Cell wall stress activates σ<sup>M</sup> (left), which up-regulates both pathways. In the absence of aPBPs, cells up-regulate elongasome activity through σ<sup>I</sup>, which increases expression of genes (<italic>mreBH</italic> and <italic>lytE</italic>) important for elongasome function. Synthetic lethal relationships are shown here between deletion of <italic>ponA</italic> and genes in the σ<sup>I</sup> pathway (black circles). Bypass of synthetic lethality can be compensated by a gain of function mutation in <italic>walK</italic> (star). (<bold>B</bold>) The promoter regions of <italic>sigI</italic>, <italic>mreBH</italic> and <italic>lytE</italic> are shown, depicting the binding sites of WalR and σ<sup>I</sup> as annotated before (<xref ref-type="bibr" rid="bib36">Huang et al., 2013</xref>). σ<sup>I</sup> and WalR act as activators for the expression of <italic>sigI</italic> and <italic>lytE</italic> from the σ<sup>A</sup> promoter. The downstream WalR binding site is important for expression of <italic>sigI</italic> and <italic>lytE</italic> at 37°C whereas the upstream binding site is crucial for the heat induction of these genes at 51°C.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57902-fig8-v1.tif"/></fig><p>Because of its unique chemical composition, PG synthesis requires numerous highly conserved enzymes, which thereby present attractive targets for antibiotics (<xref ref-type="bibr" rid="bib6">Bugg et al., 2011</xref>). Inhibitors of PG synthesis may result in spheroplast formation, cell lysis, or morphological defects, depending on the antibiotic target and the organism (<xref ref-type="bibr" rid="bib15">Cross et al., 2019</xref>; <xref ref-type="bibr" rid="bib24">Emami et al., 2017</xref>). Many of our most familiar antibiotics are natural products of soil bacteria, including <italic>Bacillus</italic> spp. (<xref ref-type="bibr" rid="bib39">Kaspar et al., 2019</xref>; <xref ref-type="bibr" rid="bib79">Stein, 2005</xref>) and many actinobacteria (<xref ref-type="bibr" rid="bib52">Mahajan, 2012</xref>). Like other soil bacteria, <italic>B. subtilis</italic> has substantial intrinsic resistance to many antibiotics (<xref ref-type="bibr" rid="bib44">Kingston et al., 2013</xref>; <xref ref-type="bibr" rid="bib64">Radeck et al., 2017a</xref>; <xref ref-type="bibr" rid="bib34">Helmann, 2016</xref>). We have explored these intrinsic resistance mechanisms by analysis of cell envelope stress responses, including those controlled by alternative sigma factors (<xref ref-type="bibr" rid="bib34">Helmann, 2016</xref>). For example, σ<sup>V</sup> is induced by and provides resistance to lysozyme by covalently modifying PG (<xref ref-type="bibr" rid="bib28">Guariglia-Oropeza and Helmann, 2011</xref>), whereas σ<sup>W</sup> is induced by and provides resistance to membrane-active bacteriocins (<xref ref-type="bibr" rid="bib7">Butcher and Helmann, 2006</xref>; <xref ref-type="bibr" rid="bib43">Kingston et al., 2011</xref>).</p><p>The σ<sup>M</sup> response is selectively induced by stresses during PG synthesis and contributes to resistance to a wide-variety of PG synthesis inhibitors, including MOE, CEF, and bacitracin (<xref ref-type="bibr" rid="bib34">Helmann, 2016</xref>; <xref ref-type="bibr" rid="bib54">Mascher et al., 2007</xref>). The σ<sup>M</sup> regulon serves to both upregulate PG synthetic capacity, and to compensate for stresses resulting from PG inhibition. The former includes the up-regulation of elongasome components (<xref ref-type="fig" rid="fig8">Figure 8A</xref>) and PG biosynthetic enzymes (PBP1, Ddl, MurB, MurF, BcrC, Amj) (<xref ref-type="bibr" rid="bib23">Eiamphungporn and Helmann, 2008</xref>). The latter includes the large regulon controlled by the Spx transcription factor that protects cells against antibiotic-associated oxidative stress (<xref ref-type="bibr" rid="bib69">Rojas-Tapias and Helmann, 2018</xref>). Finally, it has recently been shown that induction of a σ<sup>M</sup>-regulated ppGpp synthase, YwaC, increases the number of persister cells following antibiotic exposure (<xref ref-type="bibr" rid="bib26">Fung et al., 2020</xref>).</p><p>Here, we identify a major role for another alternative sigma factor, σ<sup>I</sup>, in conferring intrinsic resistance to important cell wall antibiotics, MOE and CEF. Induction of σ<sup>I</sup>, which requires the EcsAB-RasP regulatory pathway (<xref ref-type="bibr" rid="bib49">Liu et al., 2017</xref>), selectively elevates elongasome function by increasing the expression of the MreB paralog, MreBH, and the associated autolytic endopeptidase LytE (<xref ref-type="bibr" rid="bib9">Carballido-López et al., 2006</xref>). This stress response is critical in cells lacking PBP1, as judged by the synthetic lethality of Δ<italic>sigI</italic> Δ<italic>ponA</italic> mutants (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). This stress response functions in coordination with both the σ<sup>M</sup> stress response (<xref ref-type="fig" rid="fig7">Figure 7A</xref>), which increases elongasome function by upregulation of the RodA TG (<xref ref-type="bibr" rid="bib57">Meeske et al., 2016</xref>; <xref ref-type="bibr" rid="bib24">Emami et al., 2017</xref>), and the essential WalKR two-component system (<xref ref-type="fig" rid="fig6">Figures 6</xref> and <xref ref-type="fig" rid="fig8">8</xref>). Although σ<sup>I</sup> was previously linked to heat-stress (<xref ref-type="bibr" rid="bib99">Zuber et al., 2001</xref>), virulence in <italic>B. anthracis</italic> (<xref ref-type="bibr" rid="bib42">Kim and Wilson, 2016</xref>), and control of autolysin synthesis (<xref ref-type="bibr" rid="bib70">Salzberg et al., 2013</xref>), our results reveal new insights into its role in cell envelope stress.</p><p>This study also highlights the complex regulation of the <italic>mreBH</italic> and <italic>lytE</italic> genes. WalR, σ<sup>I</sup> and σ<sup>A</sup> binding sites have been previously annotated in the promoters of <italic>sigI</italic>, <italic>mreBH</italic> and <italic>lytE</italic> (<xref ref-type="fig" rid="fig8">Figure 8B</xref>). The WalK (D274A) gain of function mutant suppresses the lethal phenotype of <italic>ΔrasPΔponA</italic> by induction of <italic>mreBH</italic> and <italic>lytE</italic> (<xref ref-type="fig" rid="fig6">Figure 6</xref>). However, induction was not significant in the σ<sup>I</sup> mutant. We conclude that co-activation by WalR and σ<sup>I</sup> is required for induction of these two genes. The signals sensed by WalK are unclear, but it was recently suggested that peptidoglycan cleavage products generated by LytE and CwlO can be sensed by WalK to balance the activity of these proteins (<xref ref-type="bibr" rid="bib19">Dobihal et al., 2019</xref>). Moreover, it was previously observed that <italic>sigI</italic> activation enhances the growth of <italic>mbl</italic> mutants (<xref ref-type="bibr" rid="bib72">Schirner and Errington, 2009</xref>), which we suggest was likely due to increasing elongasome activity through <italic>mreBH</italic> and <italic>lytE</italic>.</p><p>Collectively, our results reveal that WalKR and σ<sup>I</sup> act in coordination to maintain optimal elongasome activity, and these pathways complement the general PG stress response activated by σ<sup>M</sup> (<xref ref-type="fig" rid="fig8">Figure 8</xref>). One general theme that has emerged is that PG synthesis involves multiple, functionally overlapping systems, often with one being inducible by antibiotic inhibition of the other. For example, the inducible UPP phosphatase BcrC complements the activity of UppP (<xref ref-type="bibr" rid="bib65">Radeck et al., 2017b</xref>; <xref ref-type="bibr" rid="bib96">Zhao et al., 2016</xref>), and the σ<sup>M</sup>-regulated Amj functions as a second lipid II flippase that is critical when MurJ is inhibited (<xref ref-type="bibr" rid="bib10">Chamakura et al., 2017</xref>; <xref ref-type="bibr" rid="bib56">Meeske et al., 2015</xref>). Similarly, inhibition of aPBPs by MOE leads to an essential, compensatory induction of RodA (<xref ref-type="bibr" rid="bib57">Meeske et al., 2016</xref>; <xref ref-type="bibr" rid="bib24">Emami et al., 2017</xref>). Here, it is shown that this single σ<sup>M</sup>-regulated target gene can largely account for the CEF sensitivity of <italic>sigM</italic> mutants (<xref ref-type="fig" rid="fig7">Figure 7</xref>). This increase in RodA, together with the induction of MreBH and LytE, serves to boost the biosynthetic potential of the elongasome. These results reveal mechanisms that allow diverse PG biosynthetic complexes to coordinate their activities, in both time and space. The highly orchestrated processes that direct and coordinate PG synthesis are important both for intrinsic antibiotic resistance, as explored here and are ultimately responsible for the enormous diversity of bacterial morphologies (<xref ref-type="bibr" rid="bib8">Caccamo and Brun, 2018</xref>).</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional information</th></tr></thead><tbody><tr><td>Strain, strain background (<italic>Bacillus subtilis</italic>, strain 168)</td><td>WT</td><td>Lab stock</td><td><italic>B. subtilis</italic> 168</td><td>(see Materials and methods)</td></tr><tr><td>Recombinant DNA reagent</td><td/><td>This study</td><td><italic>E. coli</italic> with pMarA1</td><td>(see Materials and methods)</td></tr><tr><td>Recombinant DNA reagent</td><td>HB20725</td><td>This study</td><td>168 pMarA1</td><td>(see Materials and methods)</td></tr><tr><td>Recombinant DNA reagent</td><td>HB20738</td><td>This study</td><td>pbpDFG null; ponA::erm;pMarA</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>Δ4 Class A PBP</td><td>This study</td><td>ponA::erm; pbpDFG::null</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ponA::erm <break/>P<sub>spank*</sub>-ponA</td><td>This study</td><td>ycgO::P<sub>spank*</sub>-ponA; <break/>ponA::erm</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>pbpDFG ponA::erm <break/>P<sub>spank*</sub>-ponA</td><td>This study</td><td>pbpDFG::null; <break/>ycgO::P<sub>spank*</sub>-ponA; ponA::erm</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ecsA ponA::erm <break/>P<sub>spank*</sub>-ponA</td><td>This study</td><td>ecsA::null; <break/>ycgO::P<sub>spank*</sub>-ponA; ponA::erm</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>pbpDFG ecsA-ponA::erm <break/>P<sub>spank*</sub>-ponA</td><td>This study</td><td>ecsA::null;pbpDFG::null; <break/>ycgO::P<sub>spank*</sub>-ponA; ponA::erm</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ytxG ponA::erm <break/>P<sub>spank*</sub>-ponA</td><td>This study</td><td>ytxG::null; <break/>ycgO::P<sub>spank*</sub>-ponA; ponA::erm</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td><italic>pbpDFG ytxG</italic> ponA::erm <break/>P<sub>spank*</sub>-ponA</td><td>This study</td><td>ytxG::null;pbpDFG::null;ycgO::P<sub>spank*</sub>-ponA; ponA::erm</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔecsA</td><td>This study</td><td>ecsA::kan</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔrasP</td><td>This study</td><td>rasP::kan</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔponA</td><td>This study</td><td>ponA::erm</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔecsAΔponA</td><td>This study</td><td>ecsA::null;ponA::erm</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔrasPΔponA</td><td>This study</td><td>rasP::null;ponA::erm</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔecsAΔrasP</td><td>This study</td><td>ecsA::null;rasP::erm</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔecsA P<sub>spac(hy)</sub>-ecsA</td><td>This study</td><td>amyE::P<sub><sub>spac(hy)</sub></sub>-ecsA; ecsA::erm</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔecsA P<sub>spac(hy)-</sub>ecsAecsB</td><td>This study</td><td>amyE::P<sub>spac(hy)</sub>-ecsAB; ecsA::erm</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔrasP P<sub>spac(hy)</sub>-rasP</td><td>This study</td><td>amyE::P<sub>spac(hy)</sub>-rasP; rasP::erm</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔsigW</td><td>This study</td><td>sigW::null</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔsigV</td><td>This study</td><td>sigV::null</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔsigI</td><td>This study</td><td>sigI::null</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>Δ25ftsL</td><td>This study</td><td>Made using CRISPR to remove the 2-26th AAs of FtsL so it is no longer a target of RasP</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔsigVΔsigW <break/>Δ25ftsLΔsigI</td><td>This study</td><td>sigV::null;sigW::null; <break/>Δ25ftsL;sigI::kan</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔsigIΔsigW</td><td>This study</td><td>sigI::null;sigW::kan</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔsigVΔsigW <break/>Δ25ftsL</td><td>This study</td><td>sigV::null;sigW::null; <break/>Δ25ftsL</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔsigIΔponA P<sub>spac(hy)</sub>-sigI</td><td>This study</td><td>sigI::null; amyE::P<sub>spac(hy)</sub>-sigI; ponA::erm</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔecsAΔsigI</td><td>This study</td><td>sigI::null;ecsA::kan</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔecsAΔsigW</td><td>This study</td><td>sigW::null;ecsA::kan</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔrasPΔsigI</td><td>This study</td><td>sigI::null;rasP::kan</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔrasPΔsigW</td><td>This study</td><td>sigW::null;rasP::kan</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔrsgI</td><td>This study</td><td>rsgI::null</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔrsiW</td><td>This study</td><td>rsiW::mls</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔecsAΔrsgI</td><td>This study</td><td>rsgI::null;ecsA::kan</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔecsAΔrsiW</td><td>This study</td><td>rsiW::mls;ecsA::kan</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔrasPΔrsgI</td><td>This study</td><td>rsgI::null;rasP::kan</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔrasPΔrsiW</td><td>This study</td><td>rsiW::mls;rasP::kan</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔsigM</td><td>This study</td><td>sigM::null</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔecsAΔsigM</td><td>This study</td><td>sigM::null;ecsA::kan</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔrasPΔsigM</td><td>This study</td><td>sigM::null;rasP::kan</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔsigIΔsigM</td><td>This study</td><td>sigM::null;sigI::kan</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>Pm*rodA</td><td><xref ref-type="bibr" rid="bib98">Zhao et al., 2019</xref></td><td>WT 168 transformed with CRISPR plasmid to remove Pm of rodA</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>Pm* maf</td><td><xref ref-type="bibr" rid="bib98">Zhao et al., 2019</xref></td><td>WT 168 transformed wth pMUTIN to introduce maf-Pm*(TGTT)</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>Pm*rodA Pm*murG</td><td>This study</td><td>Pm*murG transformed with CRISPR plasmid to remove Pm of ProdA</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>Pm*ponA</td><td>This study</td><td>WT168 transformed with CRISPR plasmid to remove Pm of ponA</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔmreBH</td><td>This study</td><td>mreBH::null</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔlytE</td><td>This study</td><td>lytE::null</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔgsiB</td><td>This study</td><td>gsiB::spec</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔfabI</td><td>This study</td><td>fabI::null</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔbcrC</td><td>This study</td><td>bcrC::null</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔmreBHΔlytE</td><td>This study</td><td>mreBH::null;lytE::null</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔmreBHΔponA</td><td>This study</td><td>mreBH::null;ponA::erm</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔlytEΔponA</td><td>This study</td><td>lytE::null;ponA::erm</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔmreBHΔlytE <break/>ΔponA</td><td>This study</td><td>mreBH::null;lytE::null; ponA::erm</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔmreBH P<sub>spac(hy)</sub>-mreBH</td><td>This study</td><td>mreBH::null; amyE::P<sub>spac(hy)</sub>-mreBH</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔlytE P<sub>spac(hy)</sub>-lytE</td><td>This study</td><td>lytE::null; <break/>amyE::P<sub>spac(hy)</sub>-lytE</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔmreBHΔlytE P<sub>xyl</sub>-mreBH</td><td>This study</td><td>mreBH::null;lytE::null; <break/>lacA::P<sub>xyl</sub>-mreBH</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔmreBHΔlytE P<sub>xyl</sub>-mreBH P<sub>spac(hy)</sub>-lytE</td><td>This study</td><td>lytE::null; amyE::P<sub>spac(hy)</sub>-lytE; <break/>lacA::P<sub>xyl</sub>-mreBH; mreBH::kan</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔrasPΔmreBH P<sub>spac(hy)</sub>-mreBH</td><td>This study</td><td>mreBH::null; amyE::P<sub>spac(hy)</sub>-mreBH; rasP::kan</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔrasPΔmreBH <break/>ΔlytE P<sub>spac(hy)</sub>-mreBH</td><td>This study</td><td>mreBH::null;lytE::null; amyE::P<sub>spac(hy)</sub>-mreBH; rasP::kan</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔsigIΔmreBH P<sub>spac(hy)-</sub>mreBH</td><td>This study</td><td>mreBH::null; amyE::P<sub>spac(hy)</sub>-mreBH; sigI::kan</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>ΔsigIΔmreBHΔlytE P<sub>spac(hy)</sub>-mreBH</td><td>This study</td><td>mreBH::null;lytE::null; amyE::P<sub>spac(hy)</sub>-mreBH; sigI::kan</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>walK*</td><td>This study</td><td>WalK<sub>D274A</sub>, constructed using CRISPR</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>walK*ΔrasP</td><td>This study</td><td>WalK<sub>D274A;</sub>rasP::kan</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>walK*ΔsigI</td><td>This study</td><td>WalK<sub>D274A;</sub>sigI::kan</td><td>(see Materials and methods)</td></tr><tr><td>Strain, strain background (<italic>Bacillus subtilis,</italic> strain 168)</td><td>walK*ΔrasPΔponA</td><td>This study</td><td>WalK<sub>D274A</sub>;rasP::kan; ponA::erm</td><td>(see Materials and methods)</td></tr><tr><td>Recombinant DNA reagent</td><td>pMarA</td><td><xref ref-type="bibr" rid="bib47">Le Breton et al., 2006</xref></td><td/><td>a plasmid harboring the mariner-Himar1 transposase</td></tr><tr><td>Recombinant DNA reagent</td><td>pMarA1</td><td/><td/><td>Modified pMarA to introduce MmeI sites</td></tr><tr><td>Recombinant DNA reagent</td><td>pDR244</td><td>BGSC (ECE274)</td><td/><td>To remove the kan/erm cassette from BKE strains</td></tr><tr><td>Recombinant DNA reagent</td><td>pAM012</td><td><xref ref-type="bibr" rid="bib56">Meeske et al., 2015</xref></td><td/><td>For Pspank*-ponA constructs</td></tr><tr><td>Recombinant DNA reagent</td><td>pPL82</td><td/><td/><td>For Pspac(hy) constructs at amyE locus</td></tr><tr><td>Recombinant DNA reagent</td><td>pBS2EXylRPxylA </td><td>BGSC (ECE741)</td><td/><td>For Pxyl constructs at lacA locus</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Bacterial strains, plasmids and growth conditions</title><p>All stains were grown in lysogeny broth (LB) medium at 37°C. Liquid cultures were aerated on an orbital shaker at 300 rpm. Glycerol stocks were streaked on LB agar plates and incubated overnight at 37°C. Conditionally synthetic lethal strains were grown in LB medium with 20 mM MgSO<sub>4</sub>.</p><p>Bacterial strains used in this study have been listed in the Key Resources Table. For all deletion mutants, primary strains were ordered from the BKK/BKE collection available at the Bacillus Genetic Stock Centre (BGSC) (<xref ref-type="bibr" rid="bib46">Koo et al., 2017</xref>). These gene deletions with the antibiotic cassette (kanamycin or erythromycin) were then transformed into our WT 168 strain using natural competence induced in modified competence (MC) medium. <italic>rasP</italic>, <italic>ecsA</italic> and <italic>ponA</italic> deletion strains had very low natural competence. Thus, other mutations were introduced using SPP1 phage transduction as described (<xref ref-type="bibr" rid="bib41">Kearns et al., 2005</xref>). The null mutants were constructed using pDR244, which removes the resistance cassette leading to clean in-frame deletions (<xref ref-type="bibr" rid="bib46">Koo et al., 2017</xref>). The resulting gene deletions (designated Δ) were confirmed with check primers listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p><p>Genes were ectopically expressed at <italic>amyE</italic> under promoter P<sub>spac(hy)</sub> using pPL82 plasmid (<xref ref-type="bibr" rid="bib63">Quisel et al., 2001</xref>). MreBH was also expressed at the <italic>lacA</italic> locus under xylose inducible promoter P<sub>xyl</sub> using plasmid pECE741 (<xref ref-type="bibr" rid="bib62">Popp et al., 2017</xref>). The respective genes were amplified from genomic DNA using primers listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. The required restriction enzyme sites (and if required a ribosome binding site (RBS)) were incorporated in the primers used for gene amplification. CRISPR-Cas9 mutagenesis was carried out using pJOE8999 plasmid as described before (<xref ref-type="bibr" rid="bib1">Altenbuchner, 2016</xref>). The primers used to construct the repair fragment and guide RNAs are in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. The whole sequence of the genes was confirmed by Sanger sequencing (Biotechnology Resources core facility at Cornell University).</p></sec><sec id="s4-2"><title>Transposon mutagenesis</title><p>The transposon-sequencing (Tn-Seq) was performed using modified pMarA (<xref ref-type="bibr" rid="bib47">Le Breton et al., 2006</xref>). pMarA is a plasmid harboring the mariner-Himar1 transposase gene and a temperature-sensitive replicon to select for transposition events. Two MmeI sites were introduced flanking the BstXI and PstI sites to generate plasmid pMarA1 (HE8334). The plasmid was transformed into WT <italic>Bacillus subtilis</italic> and Δ<italic>pbpDFG ponA::erm</italic> mutant at 28°C selecting for Kan<sup>R</sup> on LB plates supplemented with 10 mM MgSO<sub>4</sub> (final concentration) to generate strain HB20725 and HB20738, respectively. Liquid cultures of HB20725 and HB20738 harboring plasmid-borne transposons were grown at 28°C in liquid LB medium with 10 mM MgSO<sub>4</sub> to mid-exponential phase (OD<sub>600</sub> ~0.4), diluted and spread on LB plates containing kanamycin and 10 mM MgSO<sub>4</sub>. Plates were incubated overnight at 48°C to select for transposition events, and the ones with distinct single colonies (not too crowded, and about 500 colonies per plate) were pooled together. Two hundred and forty plates with a total of &gt;100,000 independent colonies were pooled together for each strain, and their genomic DNA was isolated. For each strain, 10 µg of genomic DNA was digested using MmeI, purified and ligated with sequencing adaptors. Illumina sequencing was performed and DNA adjacent to the transposon insertion sites were matched to <italic>Bacillus subtilis</italic> reference genome NC_000964.3 using CLC workbench version 8.5.1. Matching results were visualized using CLC workbench, and quantified using Tn-seq Explorer software (<xref ref-type="bibr" rid="bib78">Solaimanpour et al., 2015</xref>). For visualization of transposon insertions, IGV genome browser was used (<xref ref-type="bibr" rid="bib67">Robinson et al., 2011</xref>).</p></sec><sec id="s4-3"><title>Plating efficiency</title><p>For plating efficiency (spot dilution) assays, the cultures were grown in LB medium with 20 mM MgSO<sub>4</sub> to ~0.4 OD<sub>600</sub>. 1 mL of culture was centrifuged at 5000 rpm for 5 min and resuspended in LB medium (without MgSO<sub>4</sub>). 10-fold serial dilutions were done in LB medium and 10 µL was plated/spotted on LB agar plates, allowed to air-dry for 10–15 min, and incubated overnight at 37°C.</p></sec><sec id="s4-4"><title>Growth kinetics and MIC determinations</title><p>Cultures were grown in LB medium to ~0.4 OD<sub>600</sub>. 1 µL of this culture was inoculated in each well containing 200 µL of LB media with the required drug concentration. Honeycomb 100-well plates were used for the assay. The increase in the OD<sub>600</sub> of the culture was monitored real-time using Bioscreen C growth curve analyzer (Growth curves USA). Readings were taken at every 15 min interval up to 24 hr under constant shaking conditions at 37°C. For MIC determination, two-fold increase in the drug concentration was screened ranging from (0.2 to 1.6 µg/mL). The minimum concentration which inhibited the growth (less than 0.2 OD<sub>600</sub>) up to at least 10 hr of incubation was considered as the MIC for the strain.</p></sec><sec id="s4-5"><title>Disc diffusion assays</title><p>Antibiotic sensitivity was screened by determining the zone of inhibition using a disc diffusion assay. Cultures were allowed the grow up to ~0.4 OD<sub>600</sub>. 100 µL of this culture was added to 4 mL of top agar (0.75% agar) kept at 50°C to prevent it from solidifying. This was poured on to 15 mL LB agar plates (1.5% agar). The top agar was allowed to air-dry for 30 min. A Whatmann paper filter disc of 6 mm was then put on the top agar. The required amount of drug was added on the disc immediately. The plates were incubated overnight at 37°C and the diameter of the clear zone of inhibition was measured. For all histograms, the zone of inhibition (Y-axis) starts from 6 mm which is the disc diameter. For strains having the inducible promoter P<sub>xyl</sub>, both the top agar and LB agar plates were made with 0.1% xylose.</p></sec><sec id="s4-6"><title>Autolytic potential</title><p>200 µL of cells (~0.4 OD<sub>600</sub>) were added in each well of a 100-well honeycomb plate. To this, 0.05 M of sodium azide (from 5 M stock) was added. Immediately, the real-time monitoring of the decrease in OD<sub>600</sub> was started with Bioscreen C. Readings were taken every 15 min for up to 24 hr. The time at which 50% of the cells had lysed was noted for each mutant. The time taken (in hours) was plotted as lysis time for each strain. Sodium azide stock was prepared fresh before every experiment.</p></sec><sec id="s4-7"><title>Real-time PCR</title><p>Gene expression for <italic>mreBH</italic> and <italic>lytE</italic> was determined by real-time PCR using primers in Table S2. RNA was purified from 1.5 mL of ~0.4 OD<sub>600</sub> cells using the RNeasy Kit from Qiagen as per the manufacturer’s instructions. 2 µg of RNA was used to prepare 20 µL of cDNA to achieve a final concentration of 100 ng/µL using High capacity cDNA reverse transcription kit from Applied Biosystems. The gene expression levels were measured using 100 ng of cDNA using 0.5 µM of gene specific primers and 1X SYBR green (Bio-Rad) in CFX connect real-time system from Bio-Rad. <italic>gyrA</italic> was used a house-keeping gene. Gene expression values (2<sup>-Δct</sup>) were plotted after normalization with <italic>gyrA</italic>.</p></sec><sec id="s4-8"><title>Cell size measurements</title><p>A very thin agar pad was prepared on slides from 0.8% agarose. 10 µL of cells (~0.4 OD<sub>600</sub>) were spotted and allowed to air dry for 10 min before putting on a cover slip. Cells were imaged using Olympus BX61. Images were captured using Cooke Sensicam camera system under 100X magnification with immersion oil. The images were then analyzed for their length and width using MicrobeJ (<xref ref-type="bibr" rid="bib21">Ducret et al., 2016</xref>), a plugin for imageJ (<xref ref-type="bibr" rid="bib73">Schneider et al., 2012</xref>).</p></sec><sec id="s4-9"><title>Suppressor analysis</title><p>Spontaneous suppressors were picked from LB agar plates for <italic>ΔecsAΔponA</italic> and <italic>ΔrasPΔponA</italic>. 12 suppressors were selected from each background and their chromosomal DNA extracted using Qiagen DNA extraction kit. DNA was sequenced using the Illumina platform at the Biotechnology Resources core facility at Cornell University. The results were trimmed, mapped and aligned with the <italic>ΔecsAΔponA</italic> and <italic>ΔrasPΔponA</italic> backgrounds using CLC genomics workbench.</p></sec><sec id="s4-10"><title>Statistical analysis</title><p>All the experiments were performed with a minimum of 3 biological replicates. For microscopy images, at least 100 cells per strain were quantified for their cell length and width. One-way ANOVA was used to calculate the statistical significance. Tukey’s comparison test was used to determine significance between all the strains. P-value cut-offs have been mentioned in the figure legends. Different letters represent data which are significantly different. Same letter represents mean values which are not statistically different. Significance between two strains was determined using student’s t-test.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>Research reported in this publication was supported by the National Institutes of Health under award number R35GM122461 to JDH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.</p><p>We thank Ahmed Gaballa, Gumpanat Mahipant, Daniel Roistacher, Anna Weaver, Ivano Pezzotta, Jessica Willdigg, Chloe Murrell and Annette Choi for their contributions to the early stages of this project. We also thank Alex Meeske and David Rudner for plasmid pAM012 that contains the P<sub>spank*</sub> promoter.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Investigation, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Investigation, Methodology, Writing - original draft</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Supervision, Funding acquisition, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>List of primers used in this study.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-57902-supp1-v1.docx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-57902-transrepform-v1.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altenbuchner</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Editing of the <italic>Bacillus subtilis</italic> genome by the CRISPR-Cas9 system</article-title><source>Applied and Environmental Microbiology</source><volume>82</volume><fpage>5421</fpage><lpage>5427</lpage><pub-id pub-id-type="doi">10.1128/AEM.01453-16</pub-id><pub-id pub-id-type="pmid">27342565</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barreteau</surname> <given-names>H</given-names></name><name><surname>Kovač</surname> <given-names>A</given-names></name><name><surname>Boniface</surname> <given-names>A</given-names></name><name><surname>Sova</surname> <given-names>M</given-names></name><name><surname>Gobec</surname> <given-names>S</given-names></name><name><surname>Blanot</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Cytoplasmic steps of peptidoglycan biosynthesis</article-title><source>FEMS Microbiology Reviews</source><volume>32</volume><fpage>168</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6976.2008.00104.x</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernard</surname> <given-names>R</given-names></name><name><surname>El Ghachi</surname> <given-names>M</given-names></name><name><surname>Mengin-Lecreulx</surname> <given-names>D</given-names></name><name><surname>Chippaux</surname> <given-names>M</given-names></name><name><surname>Denizot</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>BcrC from <italic>Bacillus subtilis</italic> Acts as an Undecaprenyl Pyrophosphate Phosphatase in Bacitracin Resistance</article-title><source>Journal of Biological Chemistry</source><volume>280</volume><fpage>28852</fpage><lpage>28857</lpage><pub-id pub-id-type="doi">10.1074/jbc.M413750200</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boylan</surname> <given-names>RJ</given-names></name><name><surname>Mendelson</surname> <given-names>NH</given-names></name></person-group><year iso-8601-date="1969">1969</year><article-title>Initial characterization of a temperature-sensitive rod--mutant of <italic>Bacillus subtilis</italic></article-title><source>Journal of Bacteriology</source><volume>100</volume><fpage>1316</fpage><lpage>1321</lpage><pub-id pub-id-type="doi">10.1128/JB.100.3.1316-1321.1969</pub-id><pub-id pub-id-type="pmid">4982892</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bramkamp</surname> <given-names>M</given-names></name><name><surname>Weston</surname> <given-names>L</given-names></name><name><surname>Daniel</surname> <given-names>RA</given-names></name><name><surname>Errington</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Regulated intramembrane proteolysis of FtsL protein and the control of cell division in <italic>Bacillus subtilis</italic></article-title><source>Molecular Microbiology</source><volume>62</volume><fpage>580</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2006.05402.x</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bugg</surname> <given-names>TD</given-names></name><name><surname>Braddick</surname> <given-names>D</given-names></name><name><surname>Dowson</surname> <given-names>CG</given-names></name><name><surname>Roper</surname> <given-names>DI</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Bacterial cell wall assembly: still an attractive antibacterial target</article-title><source>Trends in Biotechnology</source><volume>29</volume><fpage>167</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1016/j.tibtech.2010.12.006</pub-id><pub-id pub-id-type="pmid">21232809</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butcher</surname> <given-names>BG</given-names></name><name><surname>Helmann</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Identification of <italic>Bacillus subtilis</italic> sigma-dependent genes that provide intrinsic resistance to antimicrobial compounds produced by bacilli</article-title><source>Molecular Microbiology</source><volume>60</volume><fpage>765</fpage><lpage>782</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2006.05131.x</pub-id><pub-id pub-id-type="pmid">16629676</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caccamo</surname> <given-names>PD</given-names></name><name><surname>Brun</surname> <given-names>YV</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The molecular basis of noncanonical bacterial morphology</article-title><source>Trends in Microbiology</source><volume>26</volume><fpage>191</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2017.09.012</pub-id><pub-id pub-id-type="pmid">29056293</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carballido-López</surname> <given-names>R</given-names></name><name><surname>Formstone</surname> <given-names>A</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Ehrlich</surname> <given-names>SD</given-names></name><name><surname>Noirot</surname> <given-names>P</given-names></name><name><surname>Errington</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Actin homolog MreBH governs cell morphogenesis by localization of the cell wall hydrolase LytE</article-title><source>Developmental Cell</source><volume>11</volume><fpage>399</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2006.07.017</pub-id><pub-id pub-id-type="pmid">16950129</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chamakura</surname> <given-names>KR</given-names></name><name><surname>Sham</surname> <given-names>L-T</given-names></name><name><surname>Davis</surname> <given-names>RM</given-names></name><name><surname>Min</surname> <given-names>L</given-names></name><name><surname>Cho</surname> <given-names>H</given-names></name><name><surname>Ruiz</surname> <given-names>N</given-names></name><name><surname>Bernhardt</surname> <given-names>TG</given-names></name><name><surname>Young</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A viral protein antibiotic inhibits lipid II flippase activity</article-title><source>Nature Microbiology</source><volume>2</volume><fpage>1480</fpage><lpage>1484</lpage><pub-id pub-id-type="doi">10.1038/s41564-017-0023-4</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>X</given-names></name><name><surname>Wong</surname> <given-names>CH</given-names></name><name><surname>Ma</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Targeting the bacterial transglycosylase: antibiotic development from a structural perspective</article-title><source>ACS Infectious Diseases</source><volume>5</volume><fpage>1493</fpage><lpage>1504</lpage><pub-id pub-id-type="doi">10.1021/acsinfecdis.9b00118</pub-id><pub-id pub-id-type="pmid">31283163</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname> <given-names>H</given-names></name><name><surname>Uehara</surname> <given-names>T</given-names></name><name><surname>Bernhardt</surname> <given-names>TG</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Beta-Lactam antibiotics induce a lethal malfunctioning of the bacterial cell wall synthesis machinery</article-title><source>Cell</source><volume>159</volume><fpage>1300</fpage><lpage>1311</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.11.017</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Claessen</surname> <given-names>D</given-names></name><name><surname>Emmins</surname> <given-names>R</given-names></name><name><surname>Hamoen</surname> <given-names>LW</given-names></name><name><surname>Daniel</surname> <given-names>RA</given-names></name><name><surname>Errington</surname> <given-names>J</given-names></name><name><surname>Edwards</surname> <given-names>DH</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Control of the cell elongation-division cycle by shuttling of PBP1 protein in <italic>Bacillus subtilis</italic></article-title><source>Molecular Microbiology</source><volume>68</volume><fpage>1029</fpage><lpage>1046</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2008.06210.x</pub-id><pub-id pub-id-type="pmid">18363795</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Claessen</surname> <given-names>D</given-names></name><name><surname>Errington</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cell wall deficiency as a coping strategy for stress</article-title><source>Trends in Microbiology</source><volume>27</volume><fpage>1025</fpage><lpage>1033</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2019.07.008</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cross</surname> <given-names>T</given-names></name><name><surname>Ransegnola</surname> <given-names>B</given-names></name><name><surname>Shin</surname> <given-names>J-H</given-names></name><name><surname>Weaver</surname> <given-names>A</given-names></name><name><surname>Fauntleroy</surname> <given-names>K</given-names></name><name><surname>VanNieuwenhze</surname> <given-names>MS</given-names></name><name><surname>Westblade</surname> <given-names>LF</given-names></name><name><surname>Dörr</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Spheroplast-Mediated carbapenem tolerance in Gram-Negative pathogens</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>63</volume><elocation-id>19</elocation-id><pub-id pub-id-type="doi">10.1128/AAC.00756-19</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delhaye</surname> <given-names>A</given-names></name><name><surname>Collet</surname> <given-names>JF</given-names></name><name><surname>Laloux</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A fly on the wall: how stress response systems can sense and respond to damage to peptidoglycan</article-title><source>Frontiers in Cellular and Infection Microbiology</source><volume>9</volume><elocation-id>380</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2019.00380</pub-id><pub-id pub-id-type="pmid">31799211</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dion</surname> <given-names>MF</given-names></name><name><surname>Kapoor</surname> <given-names>M</given-names></name><name><surname>Sun</surname> <given-names>Y</given-names></name><name><surname>Wilson</surname> <given-names>S</given-names></name><name><surname>Ryan</surname> <given-names>J</given-names></name><name><surname>Vigouroux</surname> <given-names>A</given-names></name><name><surname>van Teeffelen</surname> <given-names>S</given-names></name><name><surname>Oldenbourg</surname> <given-names>R</given-names></name><name><surname>Garner</surname> <given-names>EC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title><italic>Bacillus subtilis</italic> cell diameter is determined by the opposing actions of two distinct cell wall synthetic systems</article-title><source>Nature Microbiology</source><volume>4</volume><fpage>1294</fpage><lpage>1305</lpage><pub-id pub-id-type="doi">10.1038/s41564-019-0439-0</pub-id><pub-id pub-id-type="pmid">31086310</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Do</surname> <given-names>T</given-names></name><name><surname>Page</surname> <given-names>JE</given-names></name><name><surname>Walker</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Uncovering the activities, biological roles, and regulation of bacterial cell wall hydrolases and tailoring enzymes</article-title><source>Journal of Biological Chemistry</source><volume>295</volume><fpage>3347</fpage><lpage>3361</lpage><pub-id pub-id-type="doi">10.1074/jbc.REV119.010155</pub-id><pub-id pub-id-type="pmid">31974163</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobihal</surname> <given-names>GS</given-names></name><name><surname>Brunet</surname> <given-names>YR</given-names></name><name><surname>Flores-Kim</surname> <given-names>J</given-names></name><name><surname>Rudner</surname> <given-names>DZ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Homeostatic control of cell wall hydrolysis by the WalRK two-component signaling pathway in <italic>Bacillus subtilis</italic></article-title><source>eLife</source><volume>8</volume><elocation-id>e52088</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.52088</pub-id><pub-id pub-id-type="pmid">31808740</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domínguez-Escobar</surname> <given-names>J</given-names></name><name><surname>Chastanet</surname> <given-names>A</given-names></name><name><surname>Crevenna</surname> <given-names>AH</given-names></name><name><surname>Fromion</surname> <given-names>V</given-names></name><name><surname>Wedlich-Söldner</surname> <given-names>R</given-names></name><name><surname>Carballido-López</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Processive movement of MreB-associated cell wall biosynthetic complexes in Bacteria</article-title><source>Science</source><volume>333</volume><fpage>225</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1126/science.1203466</pub-id><pub-id pub-id-type="pmid">21636744</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ducret</surname> <given-names>A</given-names></name><name><surname>Quardokus</surname> <given-names>EM</given-names></name><name><surname>Brun</surname> <given-names>YV</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>MicrobeJ, a tool for high throughput bacterial cell detection and quantitative analysis</article-title><source>Nature Microbiology</source><volume>1</volume><elocation-id>16077</elocation-id><pub-id pub-id-type="doi">10.1038/nmicrobiol.2016.77</pub-id><pub-id pub-id-type="pmid">27572972</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egan</surname> <given-names>AJF</given-names></name><name><surname>Errington</surname> <given-names>J</given-names></name><name><surname>Vollmer</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Regulation of peptidoglycan synthesis and remodelling</article-title><source>Nature Reviews Microbiology</source><volume>18</volume><fpage>446</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1038/s41579-020-0366-3</pub-id><pub-id pub-id-type="pmid">32424210</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eiamphungporn</surname> <given-names>W</given-names></name><name><surname>Helmann</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The <italic>Bacillus subtilis</italic> sigma(M) regulon and its contribution to cell envelope stress responses</article-title><source>Molecular Microbiology</source><volume>67</volume><fpage>830</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2007.06090.x</pub-id><pub-id pub-id-type="pmid">18179421</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emami</surname> <given-names>K</given-names></name><name><surname>Guyet</surname> <given-names>A</given-names></name><name><surname>Kawai</surname> <given-names>Y</given-names></name><name><surname>Devi</surname> <given-names>J</given-names></name><name><surname>Wu</surname> <given-names>LJ</given-names></name><name><surname>Allenby</surname> <given-names>N</given-names></name><name><surname>Daniel</surname> <given-names>RA</given-names></name><name><surname>Errington</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>RodA as the missing glycosyltransferase in <italic>Bacillus subtilis</italic> and antibiotic discovery for the peptidoglycan polymerase pathway</article-title><source>Nature Microbiology</source><volume>2</volume><elocation-id>16253</elocation-id><pub-id pub-id-type="doi">10.1038/nmicrobiol.2016.253</pub-id><pub-id pub-id-type="pmid">28085152</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Formstone</surname> <given-names>A</given-names></name><name><surname>Errington</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>A magnesium-dependent <italic>mreB</italic> null mutant: implications for the role of <italic>mreB</italic> in <italic>Bacillus subtilis</italic></article-title><source>Molecular Microbiology</source><volume>55</volume><fpage>1646</fpage><lpage>1657</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2005.04506.x</pub-id><pub-id pub-id-type="pmid">15752190</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Fung</surname> <given-names>DK</given-names></name><name><surname>Barra</surname> <given-names>JT</given-names></name><name><surname>Schroeder</surname> <given-names>JW</given-names></name><name><surname>Ying</surname> <given-names>D</given-names></name><name><surname>Wang</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A shared alarmone-GTP switch underlies triggered and spontaneous persistence</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.03.22.002139</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garner</surname> <given-names>EC</given-names></name><name><surname>Bernard</surname> <given-names>R</given-names></name><name><surname>Wang</surname> <given-names>W</given-names></name><name><surname>Zhuang</surname> <given-names>X</given-names></name><name><surname>Rudner</surname> <given-names>DZ</given-names></name><name><surname>Mitchison</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Coupled, circumferential motions of the cell wall synthesis machinery and MreB filaments in <italic>B. subtilis</italic></article-title><source>Science</source><volume>333</volume><fpage>222</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1126/science.1203285</pub-id><pub-id pub-id-type="pmid">21636745</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guariglia-Oropeza</surname> <given-names>V</given-names></name><name><surname>Helmann</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title><italic>Bacillus subtilis</italic> σ(V) confers lysozyme resistance by activation of two cell wall modification pathways, peptidoglycan O-acetylation and D-alanylation of teichoic acids</article-title><source>Journal of Bacteriology</source><volume>193</volume><fpage>6223</fpage><lpage>6232</lpage><pub-id pub-id-type="doi">10.1128/JB.06023-11</pub-id><pub-id pub-id-type="pmid">21926231</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname> <given-names>MJ</given-names></name><name><surname>Middleton</surname> <given-names>RF</given-names></name><name><surname>Westmacott</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="1983">1983</year><article-title>The fractional inhibitory concentration (FIC) index as a measure of synergy</article-title><source>Journal of Antimicrobial Chemotherapy</source><volume>11</volume><fpage>427</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1093/jac/11.5.427</pub-id><pub-id pub-id-type="pmid">6874629</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname> <given-names>M</given-names></name><name><surname>Ooiwa</surname> <given-names>S</given-names></name><name><surname>Sekiguchi</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Synthetic lethality of the <italic>lytE cwlO</italic> genotype in <italic>Bacillus subtilis</italic> is caused by lack of D,L-endopeptidase activity at the lateral cell wall</article-title><source>Journal of Bacteriology</source><volume>194</volume><fpage>796</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.1128/JB.05569-11</pub-id><pub-id pub-id-type="pmid">22139507</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hastie</surname> <given-names>JL</given-names></name><name><surname>Williams</surname> <given-names>KB</given-names></name><name><surname>Ellermeier</surname> <given-names>CD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The activity of σv, an extracytoplasmic function σ factor of <italic>Bacillus subtilis</italic>, is controlled by regulated proteolysis of the anti-σ factor RsiV</article-title><source>Journal of Bacteriology</source><volume>195</volume><fpage>3135</fpage><lpage>3144</lpage><pub-id pub-id-type="doi">10.1128/JB.00292-13</pub-id><pub-id pub-id-type="pmid">23687273</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heath</surname> <given-names>RJ</given-names></name><name><surname>Su</surname> <given-names>N</given-names></name><name><surname>Murphy</surname> <given-names>CK</given-names></name><name><surname>Rock</surname> <given-names>CO</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The enoyl-[acyl-carrier-protein] reductases FabI and FabL from <italic>Bacillus subtilis</italic></article-title><source>Journal of Biological Chemistry</source><volume>275</volume><fpage>40128</fpage><lpage>40133</lpage><pub-id pub-id-type="doi">10.1074/jbc.M005611200</pub-id><pub-id pub-id-type="pmid">11007778</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinrich</surname> <given-names>J</given-names></name><name><surname>Lundén</surname> <given-names>T</given-names></name><name><surname>Kontinen</surname> <given-names>VP</given-names></name><name><surname>Wiegert</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The <italic>Bacillus subtilis</italic> ABC transporter EcsAB influences intramembrane proteolysis through RasP</article-title><source>Microbiology</source><volume>154</volume><fpage>1989</fpage><lpage>1997</lpage><pub-id pub-id-type="doi">10.1099/mic.0.2008/018648-0</pub-id><pub-id pub-id-type="pmid">18599827</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helmann</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title><italic>Bacillus subtilis</italic> extracytoplasmic function (ECF) sigma factors and defense of the cell envelope</article-title><source>Current Opinion in Microbiology</source><volume>30</volume><fpage>122</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2016.02.002</pub-id><pub-id pub-id-type="pmid">26901131</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>ZJ</given-names></name><name><surname>Edery</surname> <given-names>I</given-names></name><name><surname>Rosbash</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>PAS is a dimerization domain common to <italic>Drosophila</italic> period and several transcription factors</article-title><source>Nature</source><volume>364</volume><fpage>259</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1038/364259a0</pub-id><pub-id pub-id-type="pmid">8391649</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>WZ</given-names></name><name><surname>Wang</surname> <given-names>JJ</given-names></name><name><surname>Chen</surname> <given-names>HJ</given-names></name><name><surname>Chen</surname> <given-names>JT</given-names></name><name><surname>Shaw</surname> <given-names>GC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The heat-inducible essential response regulator WalR positively regulates transcription of <italic>sigI, mreBH</italic> and <italic>lytE</italic> in <italic>Bacillus subtilis</italic> under heat stress</article-title><source>Research in Microbiology</source><volume>164</volume><fpage>998</fpage><lpage>1008</lpage><pub-id pub-id-type="doi">10.1016/j.resmic.2013.10.003</pub-id><pub-id pub-id-type="pmid">24125693</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname> <given-names>J</given-names></name><name><surname>Zhu</surname> <given-names>F</given-names></name><name><surname>Ma</surname> <given-names>X</given-names></name><name><surname>Cao</surname> <given-names>Z</given-names></name><name><surname>Cao</surname> <given-names>ZW</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>YX</given-names></name><name><surname>Chen</surname> <given-names>YZ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Mechanisms of drug combinations: interaction and network perspectives</article-title><source>Nature Reviews Drug Discovery</source><volume>8</volume><fpage>111</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1038/nrd2683</pub-id><pub-id pub-id-type="pmid">19180105</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jolliffe</surname> <given-names>LK</given-names></name><name><surname>Doyle</surname> <given-names>RJ</given-names></name><name><surname>Streips</surname> <given-names>UN</given-names></name></person-group><year iso-8601-date="1981">1981</year><article-title>The energized membrane and cellular autolysis in <italic>Bacillus subtilis</italic></article-title><source>Cell</source><volume>25</volume><fpage>753</fpage><lpage>763</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(81)90183-5</pub-id><pub-id pub-id-type="pmid">6793239</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaspar</surname> <given-names>F</given-names></name><name><surname>Neubauer</surname> <given-names>P</given-names></name><name><surname>Gimpel</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Bioactive secondary metabolites from <italic>Bacillus subtilis</italic>: A Comprehensive Review</article-title><source>Journal of Natural Products</source><volume>82</volume><fpage>2038</fpage><lpage>2053</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.9b00110</pub-id><pub-id pub-id-type="pmid">31287310</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname> <given-names>Y</given-names></name><name><surname>Asai</surname> <given-names>K</given-names></name><name><surname>Errington</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Partial functional redundancy of MreB isoforms, MreB, mbl and MreBH, in cell morphogenesis of <italic>Bacillus subtilis</italic></article-title><source>Molecular Microbiology</source><volume>73</volume><fpage>719</fpage><lpage>731</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2009.06805.x</pub-id><pub-id pub-id-type="pmid">19659933</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kearns</surname> <given-names>DB</given-names></name><name><surname>Chu</surname> <given-names>F</given-names></name><name><surname>Branda</surname> <given-names>SS</given-names></name><name><surname>Kolter</surname> <given-names>R</given-names></name><name><surname>Losick</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>A master regulator for biofilm formation by <italic>Bacillus subtilis</italic></article-title><source>Molecular Microbiology</source><volume>55</volume><fpage>739</fpage><lpage>749</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2004.04440.x</pub-id><pub-id pub-id-type="pmid">15661000</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>JGY</given-names></name><name><surname>Wilson</surname> <given-names>AC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Loss of σ<sup>I</sup> affects heat-shock response and virulence gene expression in <italic>Bacillus anthracis</italic></article-title><source>Microbiology</source><volume>162</volume><fpage>564</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1099/mic.0.000236</pub-id><pub-id pub-id-type="pmid">26744224</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kingston</surname> <given-names>AW</given-names></name><name><surname>Subramanian</surname> <given-names>C</given-names></name><name><surname>Rock</surname> <given-names>CO</given-names></name><name><surname>Helmann</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A σW-dependent stress response in <italic>Bacillus subtilis</italic> that reduces membrane fluidity</article-title><source>Molecular Microbiology</source><volume>81</volume><fpage>69</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2011.07679.x</pub-id><pub-id pub-id-type="pmid">21542858</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kingston</surname> <given-names>AW</given-names></name><name><surname>Liao</surname> <given-names>X</given-names></name><name><surname>Helmann</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Contributions of the σ<sup>(W</sup>) , σ<sup>(M</sup>) and σ<sup>(X</sup>) regulons to the lantibiotic resistome of <italic>Bacillus subtilis</italic></article-title><source>Molecular Microbiology</source><volume>90</volume><fpage>502</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1111/mmi.12380</pub-id><pub-id pub-id-type="pmid">23980836</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname> <given-names>EY</given-names></name><name><surname>Van Boeckel</surname> <given-names>TP</given-names></name><name><surname>Martinez</surname> <given-names>EM</given-names></name><name><surname>Pant</surname> <given-names>S</given-names></name><name><surname>Gandra</surname> <given-names>S</given-names></name><name><surname>Levin</surname> <given-names>SA</given-names></name><name><surname>Goossens</surname> <given-names>H</given-names></name><name><surname>Laxminarayan</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Global increase and geographic convergence in antibiotic consumption between 2000 and 2015</article-title><source>PNAS</source><volume>115</volume><fpage>E3463</fpage><lpage>E3470</lpage><pub-id pub-id-type="doi">10.1073/pnas.1717295115</pub-id><pub-id pub-id-type="pmid">29581252</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koo</surname> <given-names>BM</given-names></name><name><surname>Kritikos</surname> <given-names>G</given-names></name><name><surname>Farelli</surname> <given-names>JD</given-names></name><name><surname>Todor</surname> <given-names>H</given-names></name><name><surname>Tong</surname> <given-names>K</given-names></name><name><surname>Kimsey</surname> <given-names>H</given-names></name><name><surname>Wapinski</surname> <given-names>I</given-names></name><name><surname>Galardini</surname> <given-names>M</given-names></name><name><surname>Cabal</surname> <given-names>A</given-names></name><name><surname>Peters</surname> <given-names>JM</given-names></name><name><surname>Hachmann</surname> <given-names>AB</given-names></name><name><surname>Rudner</surname> <given-names>DZ</given-names></name><name><surname>Allen</surname> <given-names>KN</given-names></name><name><surname>Typas</surname> <given-names>A</given-names></name><name><surname>Gross</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Construction and analysis of two Genome-Scale deletion libraries for <italic>Bacillus subtilis</italic></article-title><source>Cell Systems</source><volume>4</volume><fpage>291</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1016/j.cels.2016.12.013</pub-id><pub-id pub-id-type="pmid">28189581</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Breton</surname> <given-names>Y</given-names></name><name><surname>Mohapatra</surname> <given-names>NP</given-names></name><name><surname>Haldenwang</surname> <given-names>WG</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>In vivo random mutagenesis of <italic>Bacillus subtilis</italic> by use of TnYLB-1, a <italic>mariner</italic>-based transposon</article-title><source>Applied and Environmental Microbiology</source><volume>72</volume><fpage>327</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1128/AEM.72.1.327-333.2006</pub-id><pub-id pub-id-type="pmid">16391061</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leskelä</surname> <given-names>S</given-names></name><name><surname>Wahlström</surname> <given-names>E</given-names></name><name><surname>Hyyryläinen</surname> <given-names>HL</given-names></name><name><surname>Jacobs</surname> <given-names>M</given-names></name><name><surname>Palva</surname> <given-names>A</given-names></name><name><surname>Sarvas</surname> <given-names>M</given-names></name><name><surname>Kontinen</surname> <given-names>VP</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Ecs, an ABC transporter of <italic>Bacillus subtilis</italic>: dual signal transduction functions affecting expression of secreted proteins as well as their secretion</article-title><source>Molecular Microbiology</source><volume>31</volume><fpage>533</fpage><lpage>543</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2958.1999.01194.x</pub-id><pub-id pub-id-type="pmid">10027970</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>T-Y</given-names></name><name><surname>Chu</surname> <given-names>S-H</given-names></name><name><surname>Hu</surname> <given-names>Y-N</given-names></name><name><surname>Wang</surname> <given-names>J-J</given-names></name><name><surname>Shaw</surname> <given-names>G-C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Genetic evidence that multiple proteases are involved in modulation of heat-induced activation of the sigma factor SigI in <italic>Bacillus subtilis</italic></article-title><source>FEMS Microbiology Letters</source><volume>364</volume><elocation-id>fnx054</elocation-id><pub-id pub-id-type="doi">10.1093/femsle/fnx054</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>X</given-names></name><name><surname>Meiresonne</surname> <given-names>NY</given-names></name><name><surname>Bouhss</surname> <given-names>A</given-names></name><name><surname>den Blaauwen</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>FtsW activity and lipid II synthesis are required for recruitment of MurJ to midcell during cell division in <italic>Escherichia coli</italic></article-title><source>Molecular Microbiology</source><volume>109</volume><fpage>855</fpage><lpage>884</lpage><pub-id pub-id-type="doi">10.1111/mmi.14104</pub-id><pub-id pub-id-type="pmid">30112777</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>Y</given-names></name><name><surname>Helmann</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Analysis of the role of <italic>Bacillus subtilis</italic> σ<sup>(M</sup>) in β-lactam resistance reveals an essential role for c-di-AMP in Peptidoglycan homeostasis</article-title><source>Molecular Microbiology</source><volume>83</volume><fpage>623</fpage><lpage>639</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2011.07953.x</pub-id><pub-id pub-id-type="pmid">22211522</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahajan</surname> <given-names>GB</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Antibacterial agents from actinomycetes - A review</article-title><source>Frontiers in Bioscience</source><volume>E4</volume><fpage>240</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.2741/e373</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahone</surname> <given-names>CR</given-names></name><name><surname>Goley</surname> <given-names>ED</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Bacterial cell division at a glance</article-title><source>Journal of Cell Science</source><volume>133</volume><elocation-id>jcs237057</elocation-id><pub-id pub-id-type="doi">10.1242/jcs.237057</pub-id><pub-id pub-id-type="pmid">32269092</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mascher</surname> <given-names>T</given-names></name><name><surname>Hachmann</surname> <given-names>AB</given-names></name><name><surname>Helmann</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Regulatory overlap and functional redundancy among <italic>Bacillus subtilis</italic> extracytoplasmic function sigma factors</article-title><source>Journal of Bacteriology</source><volume>189</volume><fpage>6919</fpage><lpage>6927</lpage><pub-id pub-id-type="doi">10.1128/JB.00904-07</pub-id><pub-id pub-id-type="pmid">17675383</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McPherson</surname> <given-names>DC</given-names></name><name><surname>Popham</surname> <given-names>DL</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Peptidoglycan synthesis in the absence of class A penicillin-binding proteins in <italic>Bacillus subtilis</italic></article-title><source>Journal of Bacteriology</source><volume>185</volume><fpage>1423</fpage><lpage>1431</lpage><pub-id pub-id-type="doi">10.1128/JB.185.4.1423-1431.2003</pub-id><pub-id pub-id-type="pmid">12562814</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meeske</surname> <given-names>AJ</given-names></name><name><surname>Sham</surname> <given-names>LT</given-names></name><name><surname>Kimsey</surname> <given-names>H</given-names></name><name><surname>Koo</surname> <given-names>BM</given-names></name><name><surname>Gross</surname> <given-names>CA</given-names></name><name><surname>Bernhardt</surname> <given-names>TG</given-names></name><name><surname>Rudner</surname> <given-names>DZ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>MurJ and a novel lipid II flippase are required for cell wall biogenesis in <italic>Bacillus subtilis</italic></article-title><source>PNAS</source><volume>112</volume><fpage>6437</fpage><lpage>6442</lpage><pub-id pub-id-type="doi">10.1073/pnas.1504967112</pub-id><pub-id pub-id-type="pmid">25918422</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meeske</surname> <given-names>AJ</given-names></name><name><surname>Riley</surname> <given-names>EP</given-names></name><name><surname>Robins</surname> <given-names>WP</given-names></name><name><surname>Uehara</surname> <given-names>T</given-names></name><name><surname>Mekalanos</surname> <given-names>JJ</given-names></name><name><surname>Kahne</surname> <given-names>D</given-names></name><name><surname>Walker</surname> <given-names>S</given-names></name><name><surname>Kruse</surname> <given-names>AC</given-names></name><name><surname>Bernhardt</surname> <given-names>TG</given-names></name><name><surname>Rudner</surname> <given-names>DZ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>SEDS proteins are a widespread family of bacterial cell wall polymerases</article-title><source>Nature</source><volume>537</volume><fpage>634</fpage><lpage>638</lpage><pub-id pub-id-type="doi">10.1038/nature19331</pub-id><pub-id pub-id-type="pmid">27525505</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michna</surname> <given-names>RH</given-names></name><name><surname>Zhu</surname> <given-names>B</given-names></name><name><surname>Mäder</surname> <given-names>U</given-names></name><name><surname>Stülke</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>SubtiWiki 2.0--an integrated database for the model organism <italic>Bacillus subtilis</italic></article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>D654</fpage><lpage>D662</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv1006</pub-id><pub-id pub-id-type="pmid">26433225</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monk</surname> <given-names>IR</given-names></name><name><surname>Shaikh</surname> <given-names>N</given-names></name><name><surname>Begg</surname> <given-names>SL</given-names></name><name><surname>Gajdiss</surname> <given-names>M</given-names></name><name><surname>Sharkey</surname> <given-names>LKR</given-names></name><name><surname>Lee</surname> <given-names>JYH</given-names></name><name><surname>Pidot</surname> <given-names>SJ</given-names></name><name><surname>Seemann</surname> <given-names>T</given-names></name><name><surname>Kuiper</surname> <given-names>M</given-names></name><name><surname>Winnen</surname> <given-names>B</given-names></name><name><surname>Hvorup</surname> <given-names>R</given-names></name><name><surname>Collins</surname> <given-names>BM</given-names></name><name><surname>Bierbaum</surname> <given-names>G</given-names></name><name><surname>Udagedara</surname> <given-names>SR</given-names></name><name><surname>Morey</surname> <given-names>JR</given-names></name><name><surname>Pulyani</surname> <given-names>N</given-names></name><name><surname>Howden</surname> <given-names>BP</given-names></name><name><surname>Maher</surname> <given-names>MJ</given-names></name><name><surname>McDevitt</surname> <given-names>CA</given-names></name><name><surname>King</surname> <given-names>GF</given-names></name><name><surname>Stinear</surname> <given-names>TP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Zinc-binding to the cytoplasmic PAS domain regulates the essential WalK histidine kinase of <italic>Staphylococcus aureus</italic></article-title><source>Nature Communications</source><volume>10</volume><elocation-id>3067</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-10932-4</pub-id><pub-id pub-id-type="pmid">31296851</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Odds</surname> <given-names>FC</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Synergy, antagonism, and what the chequerboard puts between them</article-title><source>Journal of Antimicrobial Chemotherapy</source><volume>52</volume><elocation-id>1</elocation-id><pub-id pub-id-type="doi">10.1093/jac/dkg301</pub-id><pub-id pub-id-type="pmid">12805255</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Özbaykal</surname> <given-names>G</given-names></name><name><surname>Wollrab</surname> <given-names>E</given-names></name><name><surname>Simon</surname> <given-names>F</given-names></name><name><surname>Vigouroux</surname> <given-names>A</given-names></name><name><surname>Cordier</surname> <given-names>B</given-names></name><name><surname>Aristov</surname> <given-names>A</given-names></name><name><surname>Chaze</surname> <given-names>T</given-names></name><name><surname>Matondo</surname> <given-names>M</given-names></name><name><surname>van Teeffelen</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The transpeptidase PBP2 governs initial localization and activity of the major cell-wall synthesis machinery in <italic>E. coli</italic></article-title><source>eLife</source><volume>9</volume><elocation-id>e50629</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.50629</pub-id><pub-id pub-id-type="pmid">32077853</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Popp</surname> <given-names>PF</given-names></name><name><surname>Dotzler</surname> <given-names>M</given-names></name><name><surname>Radeck</surname> <given-names>J</given-names></name><name><surname>Bartels</surname> <given-names>J</given-names></name><name><surname>Mascher</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The Bacillus BioBrick box 2.0: expanding the genetic toolbox for the standardized work with <italic>Bacillus subtilis</italic></article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>15058</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-15107-z</pub-id><pub-id pub-id-type="pmid">29118374</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quisel</surname> <given-names>JD</given-names></name><name><surname>Burkholder</surname> <given-names>WF</given-names></name><name><surname>Grossman</surname> <given-names>AD</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>In vivo effects of sporulation kinases on mutant Spo0A proteins in <italic>Bacillus subtilis</italic></article-title><source>Journal of Bacteriology</source><volume>183</volume><fpage>6573</fpage><lpage>6578</lpage><pub-id pub-id-type="doi">10.1128/JB.183.22.6573-6578.2001</pub-id><pub-id pub-id-type="pmid">11673427</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radeck</surname> <given-names>J</given-names></name><name><surname>Fritz</surname> <given-names>G</given-names></name><name><surname>Mascher</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2017">2017a</year><article-title>The cell envelope stress response of <italic>Bacillus subtilis</italic>: from static signaling devices to dynamic regulatory network</article-title><source>Current Genetics</source><volume>63</volume><fpage>79</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1007/s00294-016-0624-0</pub-id><pub-id pub-id-type="pmid">27344142</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radeck</surname> <given-names>J</given-names></name><name><surname>Lautenschläger</surname> <given-names>N</given-names></name><name><surname>Mascher</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2017">2017b</year><article-title>The essential UPP phosphatase pair BcrC and UppP connects cell wall homeostasis during growth and sporulation with cell envelope stress response in <italic>Bacillus subtilis</italic></article-title><source>Frontiers in Microbiology</source><volume>8</volume><elocation-id>2403</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2017.02403</pub-id><pub-id pub-id-type="pmid">29259598</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramaniuk</surname> <given-names>O</given-names></name><name><surname>Převorovský</surname> <given-names>M</given-names></name><name><surname>Pospíšil</surname> <given-names>J</given-names></name><name><surname>Vítovská</surname> <given-names>D</given-names></name><name><surname>Kofroňová</surname> <given-names>O</given-names></name><name><surname>Benada</surname> <given-names>O</given-names></name><name><surname>Schwarz</surname> <given-names>M</given-names></name><name><surname>Šanderová</surname> <given-names>H</given-names></name><name><surname>Hnilicová</surname> <given-names>J</given-names></name><name><surname>Krásný</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>σ<sup>I</sup> from <italic>Bacillus subtilis</italic>: impact on gene expression and characterization of σ<sup>I</sup>-Dependent Transcription That Requires New Types of Promoters with Extended -35 and -10 Elements</article-title><source>Journal of Bacteriology</source><volume>200</volume><elocation-id>18</elocation-id><pub-id pub-id-type="doi">10.1128/JB.00251-18</pub-id><pub-id pub-id-type="pmid">29914988</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname> <given-names>JT</given-names></name><name><surname>Thorvaldsdóttir</surname> <given-names>H</given-names></name><name><surname>Winckler</surname> <given-names>W</given-names></name><name><surname>Guttman</surname> <given-names>M</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name><name><surname>Getz</surname> <given-names>G</given-names></name><name><surname>Mesirov</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Integrative genomics viewer</article-title><source>Nature Biotechnology</source><volume>29</volume><fpage>24</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1038/nbt.1754</pub-id><pub-id pub-id-type="pmid">21221095</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohs</surname> <given-names>PDA</given-names></name><name><surname>Buss</surname> <given-names>J</given-names></name><name><surname>Sim</surname> <given-names>SI</given-names></name><name><surname>Squyres</surname> <given-names>GR</given-names></name><name><surname>Srisuknimit</surname> <given-names>V</given-names></name><name><surname>Smith</surname> <given-names>M</given-names></name><name><surname>Cho</surname> <given-names>H</given-names></name><name><surname>Sjodt</surname> <given-names>M</given-names></name><name><surname>Kruse</surname> <given-names>AC</given-names></name><name><surname>Garner</surname> <given-names>EC</given-names></name><name><surname>Walker</surname> <given-names>S</given-names></name><name><surname>Kahne</surname> <given-names>DE</given-names></name><name><surname>Bernhardt</surname> <given-names>TG</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A central role for PBP2 in the activation of peptidoglycan polymerization by the bacterial cell elongation machinery</article-title><source>PLOS Genetics</source><volume>14</volume><elocation-id>e1007726</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1007726</pub-id><pub-id pub-id-type="pmid">30335755</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojas-Tapias</surname> <given-names>DF</given-names></name><name><surname>Helmann</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Induction of the spx regulon by cell wall stress reveals novel regulatory mechanisms in <italic>Bacillus subtilis</italic></article-title><source>Molecular Microbiology</source><volume>107</volume><fpage>659</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1111/mmi.13906</pub-id><pub-id pub-id-type="pmid">29271514</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salzberg</surname> <given-names>LI</given-names></name><name><surname>Powell</surname> <given-names>L</given-names></name><name><surname>Hokamp</surname> <given-names>K</given-names></name><name><surname>Botella</surname> <given-names>E</given-names></name><name><surname>Noone</surname> <given-names>D</given-names></name><name><surname>Devine</surname> <given-names>KM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The WalRK (YycFG) and σ(I) RsgI regulators cooperate to control CwlO and LytE expression in exponentially growing and stressed <italic>Bacillus subtilis</italic> cells</article-title><source>Molecular Microbiology</source><volume>87</volume><fpage>180</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1111/mmi.12092</pub-id><pub-id pub-id-type="pmid">23199363</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sassine</surname> <given-names>J</given-names></name><name><surname>Xu</surname> <given-names>M</given-names></name><name><surname>Sidiq</surname> <given-names>KR</given-names></name><name><surname>Emmins</surname> <given-names>R</given-names></name><name><surname>Errington</surname> <given-names>J</given-names></name><name><surname>Daniel</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Functional redundancy of division specific penicillin-binding proteins in <italic>Bacillus subtilis</italic></article-title><source>Molecular Microbiology</source><volume>106</volume><fpage>304</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1111/mmi.13765</pub-id><pub-id pub-id-type="pmid">28792086</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schirner</surname> <given-names>K</given-names></name><name><surname>Errington</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The cell wall regulator {sigma}I specifically suppresses the lethal phenotype of mbl mutants in <italic>Bacillus subtilis</italic></article-title><source>Journal of Bacteriology</source><volume>191</volume><fpage>1404</fpage><lpage>1413</lpage><pub-id pub-id-type="doi">10.1128/JB.01497-08</pub-id><pub-id pub-id-type="pmid">19114499</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname> <given-names>CA</given-names></name><name><surname>Rasband</surname> <given-names>WS</given-names></name><name><surname>Eliceiri</surname> <given-names>KW</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>NIH image to ImageJ: 25 years of image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>671</fpage><lpage>675</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2089</pub-id><pub-id pub-id-type="pmid">22930834</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schöbel</surname> <given-names>S</given-names></name><name><surname>Zellmeier</surname> <given-names>S</given-names></name><name><surname>Schumann</surname> <given-names>W</given-names></name><name><surname>Wiegert</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The <italic>Bacillus subtilis</italic> sigmaW anti-sigma factor RsiW is degraded by intramembrane proteolysis through YluC</article-title><source>Molecular Microbiology</source><volume>52</volume><fpage>1091</fpage><lpage>1105</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2004.04031.x</pub-id><pub-id pub-id-type="pmid">15130127</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sham</surname> <given-names>LT</given-names></name><name><surname>Butler</surname> <given-names>EK</given-names></name><name><surname>Lebar</surname> <given-names>MD</given-names></name><name><surname>Kahne</surname> <given-names>D</given-names></name><name><surname>Bernhardt</surname> <given-names>TG</given-names></name><name><surname>Ruiz</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Bacterial cell wall MurJ is the flippase of lipid-linked precursors for peptidoglycan biogenesis</article-title><source>Science</source><volume>345</volume><fpage>220</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1126/science.1254522</pub-id><pub-id pub-id-type="pmid">25013077</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharifzadeh</surname> <given-names>S</given-names></name><name><surname>Dempwolff</surname> <given-names>F</given-names></name><name><surname>Kearns</surname> <given-names>DB</given-names></name><name><surname>Carlson</surname> <given-names>EE</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Harnessing β-Lactam antibiotics for illumination of the activity of Penicillin-Binding proteins in <italic>Bacillus subtilis</italic></article-title><source>ACS Chemical Biology</source><volume>15</volume><fpage>1242</fpage><lpage>1251</lpage><pub-id pub-id-type="doi">10.1021/acschembio.9b00977</pub-id><pub-id pub-id-type="pmid">32155044</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname> <given-names>SK</given-names></name><name><surname>SaiSree</surname> <given-names>L</given-names></name><name><surname>Amrutha</surname> <given-names>RN</given-names></name><name><surname>Reddy</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Three redundant murein endopeptidases catalyse an essential cleavage step in peptidoglycan synthesis of <italic>Escherichia coli</italic> K12</article-title><source>Molecular Microbiology</source><volume>86</volume><fpage>1036</fpage><lpage>1051</lpage><pub-id pub-id-type="doi">10.1111/mmi.12058</pub-id><pub-id pub-id-type="pmid">23062283</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solaimanpour</surname> <given-names>S</given-names></name><name><surname>Sarmiento</surname> <given-names>F</given-names></name><name><surname>Mrázek</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Tn-seq explorer: a tool for analysis of high-throughput sequencing data of transposon mutant libraries</article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0126070</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0126070</pub-id><pub-id pub-id-type="pmid">25938432</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title><italic>Bacillus subtilis</italic> antibiotics: structures, syntheses and specific functions</article-title><source>Molecular Microbiology</source><volume>56</volume><fpage>845</fpage><lpage>857</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2005.04587.x</pub-id><pub-id pub-id-type="pmid">15853875</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taguchi</surname> <given-names>A</given-names></name><name><surname>Welsh</surname> <given-names>MA</given-names></name><name><surname>Marmont</surname> <given-names>LS</given-names></name><name><surname>Lee</surname> <given-names>W</given-names></name><name><surname>Sjodt</surname> <given-names>M</given-names></name><name><surname>Kruse</surname> <given-names>AC</given-names></name><name><surname>Kahne</surname> <given-names>D</given-names></name><name><surname>Bernhardt</surname> <given-names>TG</given-names></name><name><surname>Walker</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>FtsW is a peptidoglycan polymerase that is functional only in complex with its cognate penicillin-binding protein</article-title><source>Nature Microbiology</source><volume>4</volume><fpage>587</fpage><lpage>594</lpage><pub-id pub-id-type="doi">10.1038/s41564-018-0345-x</pub-id><pub-id pub-id-type="pmid">30692671</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takada</surname> <given-names>H</given-names></name><name><surname>Yoshikawa</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Essentiality and function of WalK/WalR two-component system: the past, present, and future of research</article-title><source>Bioscience, Biotechnology, and Biochemistry</source><volume>82</volume><fpage>741</fpage><lpage>751</lpage><pub-id pub-id-type="doi">10.1080/09168451.2018.1444466</pub-id><pub-id pub-id-type="pmid">29514560</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname> <given-names>BL</given-names></name><name><surname>Zhulin</surname> <given-names>IB</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>PAS domains: internal sensors of oxygen, redox potential, and light</article-title><source>Microbiology and Molecular Biology Reviews</source><volume>63</volume><fpage>479</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1128/MMBR.63.2.479-506.1999</pub-id><pub-id pub-id-type="pmid">10357859</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tipper</surname> <given-names>DJ</given-names></name><name><surname>Strominger</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="1965">1965</year><article-title>Mechanism of action of penicillins: a proposal based on their structural similarity to acyl-D-alanyl-D-alanine</article-title><source>PNAS</source><volume>54</volume><fpage>1133</fpage><lpage>1141</lpage><pub-id pub-id-type="doi">10.1073/pnas.54.4.1133</pub-id><pub-id pub-id-type="pmid">5219821</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tseng</surname> <given-names>CL</given-names></name><name><surname>Chen</surname> <given-names>JT</given-names></name><name><surname>Lin</surname> <given-names>JH</given-names></name><name><surname>Huang</surname> <given-names>WZ</given-names></name><name><surname>Shaw</surname> <given-names>GC</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Genetic evidence for involvement of the alternative sigma factor SigI in controlling expression of the cell wall hydrolase gene <italic>lytE</italic> and contribution of <italic>LytE</italic> to heat survival of <italic>Bacillus subtilis</italic></article-title><source>Archives of Microbiology</source><volume>193</volume><fpage>677</fpage><lpage>685</lpage><pub-id pub-id-type="doi">10.1007/s00203-011-0710-0</pub-id><pub-id pub-id-type="pmid">21541672</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Typas</surname> <given-names>A</given-names></name><name><surname>Banzhaf</surname> <given-names>M</given-names></name><name><surname>Gross</surname> <given-names>CA</given-names></name><name><surname>Vollmer</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>From the regulation of peptidoglycan synthesis to bacterial growth and morphology</article-title><source>Nature Reviews Microbiology</source><volume>10</volume><fpage>123</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1038/nrmicro2677</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Heijenoort</surname> <given-names>Y</given-names></name><name><surname>Derrien</surname> <given-names>M</given-names></name><name><surname>Van Heijenoort</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1978">1978</year><article-title>Polymerization by transglycosylation in the biosynthesis of the peptidoglycan of <italic>Escherichia coli</italic> K 12 and its inhibition by antibiotics</article-title><source>FEBS Letters</source><volume>89</volume><fpage>141</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1016/0014-5793(78)80540-7</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Heijenoort</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Lipid intermediates in the biosynthesis of bacterial peptidoglycan</article-title><source>Microbiology and Molecular Biology Reviews</source><volume>71</volume><fpage>620</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.1128/MMBR.00016-07</pub-id><pub-id pub-id-type="pmid">18063720</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vigouroux</surname> <given-names>A</given-names></name><name><surname>Cordier</surname> <given-names>B</given-names></name><name><surname>Aristov</surname> <given-names>A</given-names></name><name><surname>Alvarez</surname> <given-names>L</given-names></name><name><surname>Özbaykal</surname> <given-names>G</given-names></name><name><surname>Chaze</surname> <given-names>T</given-names></name><name><surname>Oldewurtel</surname> <given-names>ER</given-names></name><name><surname>Matondo</surname> <given-names>M</given-names></name><name><surname>Cava</surname> <given-names>F</given-names></name><name><surname>Bikard</surname> <given-names>D</given-names></name><name><surname>van Teeffelen</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Class-A penicillin binding proteins do not contribute to cell shape but repair cell-wall defects</article-title><source>eLife</source><volume>9</volume><elocation-id>e51998</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.51998</pub-id><pub-id pub-id-type="pmid">31904338</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vollmer</surname> <given-names>W</given-names></name><name><surname>Joris</surname> <given-names>B</given-names></name><name><surname>Charlier</surname> <given-names>P</given-names></name><name><surname>Foster</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Bacterial peptidoglycan (murein) hydrolases</article-title><source>FEMS Microbiology Reviews</source><volume>32</volume><fpage>259</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6976.2007.00099.x</pub-id><pub-id pub-id-type="pmid">18266855</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Chen</surname> <given-names>Z</given-names></name><name><surname>Zhao</surname> <given-names>R</given-names></name><name><surname>Jin</surname> <given-names>T</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Chen</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Deleting multiple lytic genes enhances biomass yield and production of recombinant proteins by <italic>Bacillus subtilis</italic></article-title><source>Microbial Cell Factories</source><volume>13</volume><elocation-id>129</elocation-id><pub-id pub-id-type="doi">10.1186/s12934-014-0129-9</pub-id><pub-id pub-id-type="pmid">25176138</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanakunakorn</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="1984">1984</year><article-title>Mode of action and in-vitro activity of vancomycin</article-title><source>Journal of Antimicrobial Chemotherapy</source><volume>14</volume><fpage>7</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1093/jac/14.suppl_D.7</pub-id><pub-id pub-id-type="pmid">6440886</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waxman</surname> <given-names>DJ</given-names></name><name><surname>Yu</surname> <given-names>W</given-names></name><name><surname>Strominger</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="1980">1980</year><article-title>Linear, uncross-linked peptidoglycan secreted by penicillin-treated <italic>Bacillus subtilis</italic> Isolation and characterization as a substrate for penicillin-sensitive D-alanine carboxypeptidases</article-title><source>Journal of Biological Chemistry</source><volume>255</volume><fpage>11577</fpage><lpage>11587</lpage></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname> <given-names>Y</given-names></name><name><surname>Havasy</surname> <given-names>T</given-names></name><name><surname>McPherson</surname> <given-names>DC</given-names></name><name><surname>Popham</surname> <given-names>DL</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Rod shape determination by the <italic>Bacillus subtilis</italic> class B penicillin-binding proteins encoded by <italic>pbpA</italic> and <italic>pbpH</italic></article-title><source>Journal of Bacteriology</source><volume>185</volume><fpage>4717</fpage><lpage>4726</lpage><pub-id pub-id-type="doi">10.1128/JB.185.16.4717-4726.2003</pub-id><pub-id pub-id-type="pmid">12896990</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiedemann</surname> <given-names>I</given-names></name><name><surname>Breukink</surname> <given-names>E</given-names></name><name><surname>van Kraaij</surname> <given-names>C</given-names></name><name><surname>Kuipers</surname> <given-names>OP</given-names></name><name><surname>Bierbaum</surname> <given-names>G</given-names></name><name><surname>de Kruijff</surname> <given-names>B</given-names></name><name><surname>Sahl</surname> <given-names>HG</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity</article-title><source>Journal of Biological Chemistry</source><volume>276</volume><fpage>1772</fpage><lpage>1779</lpage><pub-id pub-id-type="doi">10.1074/jbc.M006770200</pub-id><pub-id pub-id-type="pmid">11038353</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yilancioglu</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Antimicrobial drug interactions: systematic evaluation of protein and nucleic acid synthesis inhibitors</article-title><source>Antibiotics</source><volume>8</volume><elocation-id>114</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics8030114</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>H</given-names></name><name><surname>Sun</surname> <given-names>Y</given-names></name><name><surname>Peters</surname> <given-names>JM</given-names></name><name><surname>Gross</surname> <given-names>CA</given-names></name><name><surname>Garner</surname> <given-names>EC</given-names></name><name><surname>Helmann</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Depletion of undecaprenyl pyrophosphate phosphatases disrupts cell envelope biogenesis in <italic>Bacillus subtilis</italic></article-title><source>Journal of Bacteriology</source><volume>198</volume><fpage>2925</fpage><lpage>2935</lpage><pub-id pub-id-type="doi">10.1128/JB.00507-16</pub-id><pub-id pub-id-type="pmid">27528508</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>H</given-names></name><name><surname>Patel</surname> <given-names>V</given-names></name><name><surname>Helmann</surname> <given-names>JD</given-names></name><name><surname>Dörr</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Don't let sleeping dogmas lie: new views of peptidoglycan synthesis and its regulation</article-title><source>Molecular Microbiology</source><volume>106</volume><fpage>847</fpage><lpage>860</lpage><pub-id pub-id-type="doi">10.1111/mmi.13853</pub-id><pub-id pub-id-type="pmid">28975672</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>H</given-names></name><name><surname>Sachla</surname> <given-names>AJ</given-names></name><name><surname>Helmann</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Mutations of the <italic>Bacillus subtilis</italic> YidC1 (SpoIIIJ) insertase alleviate stress associated with σM-dependent membrane protein overproduction</article-title><source>PLOS Genetics</source><volume>15</volume><elocation-id>e1008263</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1008263</pub-id><pub-id pub-id-type="pmid">31626625</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuber</surname> <given-names>U</given-names></name><name><surname>Drzewiecki</surname> <given-names>K</given-names></name><name><surname>Hecker</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Putative sigma factor SigI (YkoZ) of <italic>Bacillus subtilis</italic> is induced by heat shock</article-title><source>Journal of Bacteriology</source><volume>183</volume><fpage>1472</fpage><lpage>1475</lpage><pub-id pub-id-type="doi">10.1128/JB.183.4.1472-1475.2001</pub-id><pub-id pub-id-type="pmid">11157964</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.57902.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Levin</surname><given-names>Petra Anne</given-names></name><role>Reviewing Editor</role><aff><institution>Washington University in St. Louis</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Garner</surname><given-names>Ethan C</given-names></name><role>Reviewer</role><aff><institution>Harvard University</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This study nicely illuminates the finely tuned connections between different aspects of cell wall synthesis and the ability of <italic>Bacillus subtilis</italic> to enhance the activity of one set of enzymes to compensate for defects in another. This flexibility helps ensure the cell envelope remains a robust barrier in the face of diverse environmental stress.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;A regulatory pathway that selectively up-regulates elongasome function in the absence of class A PBPs&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Gisela Storz as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Petra Levin (Reviewer #1) Ethan C Garner (Reviewer #2).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>As the editors have judged that your manuscript is of interest, but as described below that additional experiments are required before it is published, we would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). First, because many researchers have temporarily lost access to the labs, we will give authors as much time as they need to submit revised manuscripts. We are also offering, if you choose, to post the manuscript to bioRxiv (if it is not already there) along with this decision letter and a formal designation that the manuscript is &quot;in revision at <italic>eLife</italic>&quot;. Please let us know if you would like to pursue this option. (If your work is more suitable for medRxiv, you will need to post the preprint yourself, as the mechanisms for us to do so are still in development.)</p><p>Overall, the reviewers thought that the work provides important insight into how <italic>Bacillus subtilis</italic> is able to compensate for loss of class aPBP activity via upregulation of LytE under the control of SigI and WalRK. At the same time, we felt that several conclusions required additional experiments to be fully supported. Specifically:</p><p>1) Data indicating that cefuroxime preferentially targets PBP1.</p><p>2) Width measurements of single knockout controls of LytE and MreBH, and/or data on how induction (or titration) of one or the other affects width.</p><p>Not essential, although both would strengthen the manuscript, are experiments assessing the potential for RasP/WalRK to control minor aPBPs and the impact of <italic>mreBH</italic> and <italic>lytE</italic> expression and their ability to bypass the aPBPs in <italic>ΔrasP</italic>/<italic>ΔsigI</italic> cells.</p><p>Equally important, all three reviewers found the manuscript difficult to read, and felt it would be even more so for <italic>eLife</italic> readers who are not familiar with peptidoglycan biosynthesis and cell envelope stress response pathways in <italic>B. subtilis</italic>, or less comfortable with genetic approaches. For convenience, specific reviewer comments related to textual revisions are at the end of this letter. We would like you to pay particular attention to these comments and ensure that the revised manuscript is accessible to the broad audience that reads <italic>eLife</italic>.</p><p>1) The authors propose that activation of LytE bypasses the requirement for aPBPs through activation of the elongasome specific TGase, RodA (citing a 2016 Rudner lab paper) and presumably its associated TP enzymes. While exciting if correct, it is unclear specifically how activation of a TGase is sufficient to bypass both the TG and TP activity of the a PBPs and what this means for the growth and physiology of the cell. If there is substantial data explaining how activation of the TGase also leads to activation of its corresponding TPase, this information should be included in the text.</p><p>2) “We next sought to identify antibiotics that, unlike MOE, inhibit aPBPs at their TP active site, and can thereby lead to futile cycling.” “This resulted in synergistic inhibition (Figure 2—figure supplement 2), consistent with the same target drug synergy model, as previously described for <italic>E. coli</italic> protein synthesis inhibitors (Yilancioglu, 2019) and drugs used to treat human diseases (Jia et al., 2009). Taken together, our results suggest that CEF preferentially targets PBP1”.</p><p>The explanation in this section is incredibly vague and confusing, and it should be clarified. One point specifically, is they invoke the &quot;same target drug synergy model&quot;, without definition or explanation. This should be explained better.</p><p>Similarly, they introduce this section looking for &quot;antibiotics that, unlike MOE, inhibit aPBPs at their TP active site, and can thereby lead to futile cycling Given they do not test futile cycling in any manner, have no controls or data on this point, nor further explanation, this should be removed.</p><p>3) Information in their model Figure 8) is not all that informative, nor that descriptive to the findings presented in this study or their model. This could be improved with a gene diagram (or equivalent) explaining better the different synthetic systems, reporters, and signaling circuits.</p><p>4) The authors rightly note that &quot;insertion of new glycan strands requires endopeptidases that can cleave existing crosslinks to facilitate cell wall expansion.&quot; While the authors reference a 2008 review, a more appropriate reference might be the 2012 study from Manjula Reddy's group (Singh et al., 2012), which established endopeptidases as the long-anticipated 'space-maker' hydrolases.</p><p>5) &quot;A RodA paralog, FtsW, provides TG activity in the context of the divisome (Gamba et al., 2009a).&quot; The authors should also reference the 2019 study from Suzanne Walker's group (Taguchi et al., 2019), which showed transglycosylase activity for FtsW for the first time.</p><p>6) &quot;These results suggest that the σI stress response acts in concert with WalKR to maintain activity of the elongasome by upregulating its associated autolysin, and this mechanism serves to balance the synthetic activities of the elongasome and aPBPs.&quot; The authors may want to consider being even more circumspect in their conclusion. The uninitiated reader may not appreciate the nuance of using a hyperactive variant of WalK (WalK*).</p><p>7) &quot;Mutations that impair PG synthesis can often be rescued by growth on plates amended with 20 mM MgSO4 (Formstone and Errington, 2005).&quot; The authors should take a moment here to explain that Mg<sup>2+</sup> suppresses cell wall defects in <italic>B. subtilis</italic> by inhibiting autolysins (PMID 28317238), which is interesting since the authors show increased <italic>lytE</italic> expression in <italic>ΔponA</italic> cells (Figure 4E). Explaining the suppressive role of Mg<sup>2+</sup> on autolysin activity would further support the authors' claim that directed LytE activity is important for cell survival (subsections “EcsAB-RasP functions through σ<sup>I</sup> to sustain cell wall synthesis in the absence of aPBPs”, “σ<sup>I</sup> supports elongasome function by regulating MreBH and LytE” and “Balance in the MreBH-LytE activity is essential for optimal elongasome function”).</p><p>8) Subsection “The EcsAB-RasP pathway is essential in the absence of class A PBPs”, Figure 1B: Please comment on the colony morphology of <italic>ΔrasPΔponA</italic> cells? The colonies look mucoidy and there appear to be suppressors.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.57902.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Overall, the reviewers thought that the work provides important insight into how <italic>Bacillus subtilis</italic> is able to compensate for loss of class aPBP activity via upregulation of LytE under the control of SigI and WalRK. At the same time, we felt that several conclusions required additional experiments to be fully supported. Specifically:</p><p>1) Data indicating that cefuroxime preferentially targets PBP1.</p></disp-quote><p>This is already established in the literature and the relevant references are cited in the subsection “Mutants defective in the EcsAB-RasP pathway are sensitive to antibiotics that inhibit aPBPs”.</p><disp-quote content-type="editor-comment"><p>2) Width measurements of single knockout controls of LytE and MreBH, and/or data on how induction (or titration) of one or the other affects width.</p></disp-quote><p>Once labs re-opened we returned to this question and gathered additional data for the <italic>lytE</italic> and <italic>mreBH</italic> single mutant strains. These are presented in revised Figure 5C and D.</p><disp-quote content-type="editor-comment"><p>Not essential, although both would strengthen the manuscript, are experiments assessing the potential for RasP/WalRK to control minor aPBPs and the impact of mreBH and lytE expression and their ability to bypass the aPBPs in ΔrasP/ΔsigI cells.</p></disp-quote><p>All of our results point to the idea that RasP works through SigI, and the relevant target is MreBH which works with LytE. The SigI and WalR regulons are known, and the targets do not include any PBPs.</p><p>We have confirmed that the CEF sensitivity in a <italic>rasP</italic> mutant is the same as in the strain lacking the three minor aPBPs. In addition, induction of <italic>mreBH</italic> rescues the <italic>rasP</italic> mutant, and this rescue is also seen in a strain lacking the three minor aPBPs (this is now mentioned in the paper).</p><disp-quote content-type="editor-comment"><p>Equally important, all three reviewers found the manuscript difficult to read, and felt it would be even more so for eLife readers who are not familiar with peptidoglycan biosynthesis and cell envelope stress response pathways in <italic>B. subtilis</italic>, or less comfortable with genetic approaches. For convenience, specific reviewer comments related to textual revisions are at the end of this letter. We would like you to pay particular attention to these comments and ensure that the revised manuscript is accessible to the broad audience that reads eLife.</p></disp-quote><p>We have modified the text in several places to address those sections that were deemed unclear.</p><disp-quote content-type="editor-comment"><p>1) The authors propose that activation of LytE bypasses the requirement for aPBPs through activation of the elongasome specific TGase, RodA (citing a 2016 Rudner lab paper) and presumably its associated TP enzymes. While exciting if correct, it is unclear specifically how activation of a TGase is sufficient to bypass both the TG and TP activity of the a PBPs and what this means for the growth and physiology of the cell. If there is substantial data explaining how activation of the TGase also leads to activation of its corresponding TPase, this information should be included in the text.</p></disp-quote><p>We apologize for the confusion. We did not mean to imply that RodA replaces class aPBPs. RodA only provides TG activity, and must work together with one of two class bPBPs. Our study indicates that this synthetic complex (RodA + bPBP) can regulated by changing the amount of MreBH<sup>+</sup>LytE, which promotes localized degradation of PG to allow incorporation of new strands.</p><disp-quote content-type="editor-comment"><p>2) “We next sought to identify antibiotics that, unlike MOE, inhibit aPBPs at their TP active site, and can thereby lead to futile cycling.” “This resulted in synergistic inhibition (Figure 2—figure supplement 2), consistent with the same target drug synergy model, as previously described for <italic>E. coli</italic> protein synthesis inhibitors (Yilancioglu, 2019) and drugs used to treat human diseases (Jia et al., 2009). Taken together, our results suggest that CEF preferentially targets PBP1”.The explanation in this section is incredibly vague and confusing, and it should be clarified. One point specifically, is they invoke the &quot;same target drug synergy model&quot;, without definition or explanation. This should be explained better.</p></disp-quote><p>We appreciate that this section was not well organized and the logical flow was not clear. This entire section has been re-written for clarity. (subsection “Mutants defective in the EcsAB-RasP pathway are sensitive to antibiotics that inhibit aPBPs”).</p><disp-quote content-type="editor-comment"><p>Similarly, they introduce this section looking for &quot;antibiotics that, unlike MOE, inhibit aPBPs at their TP active site, and can thereby lead to futile cycling Given they do not test futile cycling in any manner, have no controls or data on this point, nor further explanation, this should be removed.</p></disp-quote><p>This is the same section (subsection “Mutants defective in the EcsAB-RasP pathway are sensitive to antibiotics that inhibit aPBPs”) noted above and has been re-written. In fact, we did test the hypothesis of futile cycling by asking whether CEF and MOE were antagonistic. However, we found instead that their activities were synergistic, which is not consistent with futile cycling.</p><disp-quote content-type="editor-comment"><p>3) Information in their model Figure 8) is not all that informative, nor that descriptive to the findings presented in this study or their model. This could be improved with a gene diagram (or equivalent) explaining better the different synthetic systems, reporters, and signaling circuits.</p></disp-quote><p>We agree that the model was not as clear as it could have been. We now provide a re-envisioned Figure 8 which makes the relationships much clearer.</p><disp-quote content-type="editor-comment"><p>4) The authors rightly note that &quot;insertion of new glycan strands requires endopeptidases that can cleave existing crosslinks to facilitate cell wall expansion.&quot; While the authors reference a 2008 review, a more appropriate reference might be the 2012 study from Manjula Reddy's group (Singh et al., 2012), which established endopeptidases as the long-anticipated 'space-maker' hydrolases.</p></disp-quote><p>We have carefully reviewed all citations and included the suggested citations as requested. In addition, citations have been updated were needed.</p><disp-quote content-type="editor-comment"><p>5) &quot;A RodA paralog, FtsW, provides TG activity in the context of the divisome (Gamba et al., 2009a).&quot; The authors should also reference the 2019 study from Suzanne Walker's group (Taguchi et al., 2019), which showed transglycosylase activity for FtsW for the first time.</p></disp-quote><p>We have included the suggested citation as requested.</p><disp-quote content-type="editor-comment"><p>6) &quot;These results suggest that the σ<sup>I</sup> stress response acts in concert with WalKR to maintain activity of the elongasome by upregulating its associated autolysin, and this mechanism serves to balance the synthetic activities of the elongasome and aPBPs.&quot; The authors may want to consider being even more circumspect in their conclusion. The uninitiated reader may not appreciate the nuance of using a hyperactive variant of WalK (WalK*).</p></disp-quote><p>This text has been revised to be more circumspect, as requested. Rather than stating that this “serves” to balance the activities, we say that it “helps to maintain balanced activity of the elongasome and the aPBPs during cell elongation.”</p><disp-quote content-type="editor-comment"><p>7) &quot;Mutations that impair PG synthesis can often be rescued by growth on plates amended with 20 mM MgSO4 (Formstone and Errington, 2005).&quot; The authors should take a moment here to explain that Mg<sup>2+</sup> suppresses cell wall defects in <italic>B. subtilis</italic> by inhibiting autolysins (PMID 28317238), which is interesting since the authors show increased lytE expression in ΔponA cells (Figure 4E). Explaining the suppressive role of Mg<sup>2+</sup> on autolysin activity would further support the authors' claim that directed LytE activity is important for cell survival (subsections “EcsAB-RasP functions through σ<sup>I</sup> to sustain cell wall synthesis in the absence of aPBPs”, “σ<sup>I</sup> supports elongasome function by regulating MreBH and LytE” and “Balance in the MreBH-LytE activity is essential for optimal elongasome function”).</p></disp-quote><p>We thank the reviewer for this suggestion. We now include a clearer description of how Mg supplementation works when first introduced, and specifically highlight the role in suppression of autolysin activity (subsection “The EcsAB-RasP pathway is essential in the absence of class A PBPs”).</p><disp-quote content-type="editor-comment"><p>8) Subsection “The EcsAB-RasP pathway is essential in the absence of class A PBPs”, Figure 1B: Please comment on the colony morphology of ΔrasP ΔponA cells? The colonies look mucoidy and there appear to be suppressors.</p></disp-quote><p>The image has been replaced. The colonies are not mucoid, but they are slow-growing and in the original image some suppressors were apparent, as the referee noted.</p></body></sub-article></article>